STAT3	B-protein
is	O
a	O
serine	B-protein
kinase	I-protein
target	I-protein
in	O
T	B-cell_type
lymphocytes	I-cell_type
.	O

Interleukin	B-protein
2	I-protein
and	O
T	B-protein
cell	I-protein
antigen	I-protein
receptor	I-protein
signals	O
converge	O
upon	O
serine	O
727	O
.	O

Interleukin	B-protein
2	I-protein
(	O
IL-2	B-protein
)	O
induces	O
tyrosine	O
phosphorylation	O
of	O
STATs	B-protein
3	I-protein
and	I-protein
5	I-protein
(	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
)	O
.	O

We	O
now	O
show	O
that	O
IL-2	B-protein
regulation	O
of	O
STAT3	B-protein
proteins	I-protein
in	O
T	B-cell_type
cells	I-cell_type
is	O
a	O
complex	O
response	O
involving	O
activation	O
of	O
two	O
forms	O
of	O
STAT3	B-protein
:	O
90-kDa	O
STAT3alpha	B-protein
and	O
an	O
83-kDa	B-protein
carboxyl-terminal	I-protein
truncated	I-protein
STAT3beta	I-protein
.	O

The	O
phosphorylation	O
of	O
STAT	B-protein
proteins	I-protein
on	O
serine	O
residues	O
is	O
also	O
required	O
for	O
competent	O
STAT	B-protein
transcription	O
.	O

A	O
critical	O
serine	B-protein
phosphorylation	I-protein
site	I-protein
in	O
STAT3alpha	B-protein
is	O
at	O
position	O
727	O
.	O

In	O
this	O
study	O
we	O
have	O
produced	O
an	O
antisera	O
specific	O
for	O
STAT3alpha	B-protein
proteins	I-protein
phosphorylated	O
on	O
serine	O
727	O
and	O
used	O
this	O
to	O
monitor	O
the	O
phosphorylation	O
of	O
this	O
residue	O
during	O
T	O
lymphocyte	O
activation	O
.	O

Our	O
results	O
show	O
that	O
phosphorylation	O
of	O
STAT3alpha	B-protein
on	O
serine	O
727	O
is	O
not	O
constitutive	O
in	O
quiescent	B-cell_type
T	I-cell_type
cells	I-cell_type
but	O
can	O
be	O
induced	O
by	O
the	O
cytokine	B-protein
IL-2	I-protein
.	O

Interestingly	O
,	O
triggering	O
of	O
the	O
T	B-protein
cell	I-protein
antigen	I-protein
receptor	I-protein
complex	I-protein
or	O
activation	O
of	O
protein	B-protein
kinase	I-protein
C	I-protein
with	O
phorbol	O
esters	O
also	O
induces	O
phosphorylation	O
of	O
serine	O
727	O
but	O
without	O
simultaneously	O
inducing	O
STAT3	B-protein
tyrosine	O
phosphorylation	O
or	O
DNA	O
binding	O
.	O

Hence	O
,	O
the	O
present	O
results	O
show	O
that	O
STAT3	B-protein
serine	O
phosphorylation	O
can	O
be	O
regulated	O
independently	O
of	O
the	O
tyrosine	O
phosphorylation	O
of	O
this	O
molecule	O
.	O

IL-2	B-protein
and	O
T	B-protein
cell	I-protein
antigen	I-protein
receptor	I-protein
complex	I-protein
induction	O
of	O
STAT3alpha	B-protein
serine	O
727	O
phosphorylation	O
is	O
dependent	O
on	O
the	O
activity	O
of	O
the	O
MEK	B-protein
/ERK	B-protein
pathway	O
.	O

Previous	O
studies	O
have	O
identified	O
H-7-sensitive	O
kinase	O
pathways	O
that	O
regulate	O
STAT3	B-protein
DNA	O
binding	O
.	O

We	O
show	O
that	O
H-7-sensitive	O
pathways	O
regulate	O
STAT3	B-protein
DNA	O
binding	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

Nevertheless	O
,	O
we	O
show	O
that	O
H-7-sensitive	B-protein
kinases	I-protein
do	O
not	O
regulate	O
STAT3	B-protein
tyrosine	O
phosphorylation	O
or	O
phosphorylation	O
of	O
serine	O
727	O
.	O

These	O
results	O
thus	O
show	O
that	O
STAT3	B-protein
proteins	I-protein
are	O
targets	O
for	O
multiple	O
kinase	O
pathways	O
in	O
T	B-cell_type
cells	I-cell_type
and	O
can	O
integrate	O
signals	O
from	O
both	O
cytokine	B-protein
receptors	I-protein
and	O
antigen	B-protein
receptors	I-protein
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

272	NULL
,	NULL
No	NULL
.	NULL

39	NULL
,	NULL
Issue	NULL
of	NULL
September	NULL
26	NULL
,	NULL
pp	NULL
.	NULL

24542-24549	NULL
,	NULL
1997	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
STAT3	NULL
Is	NULL
a	NULL
Serine	NULL
Kinase	NULL
Target	NULL
in	NULL
T	NULL
Lymphocytes	NULL
INTERLEUKIN	NULL
2	NULL
AND	NULL
T	NULL
CELL	NULL
ANTIGEN	NULL
RECEPTOR	NULL
SIGNALS	NULL
CONVERGE	NULL
UPON	NULL
SERINE	NULL
727*	NULL
Julian	NULL
Ng	NULL
and	NULL
Doreen	NULL
Cantrell	NULL
}	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
June	NULL
3	NULL
,	NULL
1997	NULL
)	NULL
From	NULL
the	NULL
Lymphocyte	NULL
Activation	NULL
Laboratory	NULL
,	NULL
Imperial	NULL
Cancer	NULL
Research	NULL
Fund	NULL
Laboratories	NULL
,	NULL
44	NULL
,	NULL
Lincoln	NULL
's	NULL
Inn	NULL
Fields	NULL
,	NULL
London	NULL
WCZA	NULL
3PX	NULL
,	NULL
United	NULL
Kingdom	NULL
Interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STATs	NULL
3	NULL
and	NULL
5	NULL
(	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
)	NULL
.	NULL

We	NULL
now	NULL
show	NULL
that	NULL
IL-2	NULL
regulation	NULL
of	NULL
STAT3	NULL
proteins	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
a	NULL
complex	NULL
response	NULL
involving	NULL
activation	NULL
of	NULL
two	NULL
forms	NULL
of	NULL
STAT3	NULL
:	NULL
90-kDa	NULL
STAT3	NULL
«	NULL
and	NULL
an	NULL
83-kDa	NULL
carboxyl-terminal	NULL
truncated	NULL
STAT3RB	NULL
.	NULL

The	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
proteins	NULL
on	NULL
serine	NULL
residues	NULL
is	NULL
also	NULL
required	NULL
for	NULL
competent	NULL
STAT	NULL
transcription	NULL
.	NULL

A	NULL
critical	NULL
serine	NULL
phosphorylation	NULL
site	NULL
in	NULL
STAT3	NULL
«	NULL
is	NULL
at	NULL
position	NULL
727	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
have	NULL
produced	NULL
an	NULL
antisera	NULL
specific	NULL
for	NULL
STAT3a	NULL
«	NULL
proteins	NULL
phosphorylated	NULL
on	NULL
serine	NULL
727	NULL
and	NULL
used	NULL
this	NULL
to	NULL
monitor	NULL
the	NULL
phosphorylation	NULL
of	NULL
this	NULL
residue	NULL
during	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
«	NULL
on	NULL
serine	NULL
727	NULL
is	NULL
not	NULL
constitutive	NULL
in	NULL
quiescent	NULL
T	NULL
cells	NULL
but	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
the	NULL
cytokine	NULL
IL-2	NULL
.	NULL

Interestingly	NULL
,	NULL
triggering	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
complex	NULL
or	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
with	NULL
phorbol	NULL
esters	NULL
also	NULL
induces	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
but	NULL
without	NULL
simultaneously	NULL
inducing	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
or	NULL
DNA	NULL
binding	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
present	NULL
results	NULL
show	NULL
that	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
can	NULL
be	NULL
regulated	NULL
independently	NULL
of	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
this	NULL
molecule	NULL
.	NULL

IL-2	NULL
and	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
complex	NULL
induction	NULL
of	NULL
STAT3	NULL
«	NULL
@	NULL
serine	NULL
727	NULL
phosphorylation	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
MEK/ERK	NULL
pathway	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
identified	NULL
H-7-sensitive	NULL
kinase	NULL
pathways	NULL
that	NULL
regulate	NULL
STAT3	NULL
DNA	NULL
binding	NULL
.	NULL

We	NULL
show	NULL
that	NULL
H-7-sensitive	NULL
pathways	NULL
regulate	NULL
STAT3	NULL
DNA	NULL
binding	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nevertheless	NULL
,	NULL
we	NULL
show	NULL
that	NULL
H-7-sensitive	NULL
kinases	NULL
do	NULL
not	NULL
regulate	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
or	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
.	NULL

These	NULL
results	NULL
thus	NULL
show	NULL
that	NULL
STAT3	NULL
proteins	NULL
are	NULL
targets	NULL
for	NULL
multiple	NULL
kinase	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
can	NULL
integrate	NULL
signals	NULL
from	NULL
both	NULL
cytokine	NULL
receptors	NULL
and	NULL
antigen	NULL
receptors	NULL
.	NULL

The	NULL
cytokine	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
``	NULL
controls	NULL
G	NULL
;	NULL
-S	NULL
phase	NULL
pro-gression	NULL
,	NULL
T	NULL
cell	NULL
clonal	NULL
expansion	NULL
,	NULL
and	NULL
functional	NULL
differentiation	NULL
(	NULL
1	NULL
)	NULL
.	NULL

High	NULL
affinity	NULL
IL-2	NULL
receptors	NULL
trigger	NULL
activation	NULL
of	NULL
tyrosine	NULL
kinases	NULL
notably	NULL
the	NULL
Janus	NULL
kinases	NULL
(	NULL
JAKs	NULL
)	NULL
1	NULL
and	NULL
3	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
and	NULL
p56	NULL
``	NULL
**	NULL
(	NULL
4	NULL
)	NULL
.	NULL

IL-2	NULL
also	NULL
regulates	NULL
the	NULL
activity	NULL
of	NULL
p21	NULL
``	NULL
(	NULL
5	NULL
)	NULL
,	NULL
the	NULL
kinases	NULL
Raf-1	NULL
(	NULL
6	NULL
)	NULL
,	NULL
and	NULL
ERK	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
,	NULL
phosphatidylinositol	NULL
3-kinase	NULL
(	NULL
9-11	NULL
)	NULL
,	NULL
and	NULL
p7O	NULL
S6	NULL
kinase	NULL
(	NULL
12-14	NULL
)	NULL
.	NULL

*	NULL
The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

{	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
44-171-269-3307	NULL
;	NULL
Fax	NULL
:	NULL
44-171-269-8479	NULL
.	NULL

*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IL-2	NULL
,	NULL
interleukin	NULL
2	NULL
;	NULL
IFN	NULL
,	NULL
interferon	NULL
;	NULL
MAP	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
;	NULL
MEK	NULL
,	NULL
MAP	NULL
kinase	NULL
kinase	NULL
;	NULL
PDBu	NULL
,	NULL
phorbol	NULL
12,13-dibutyrate	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
;	NULL
ELISA	NULL
,	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
;	NULL
SIEM	NULL
,	NULL
sis-inducible	NULL
element	NULL
mutant	NULL
;	NULL
TCR	NULL
,	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
complex	NULL
.	NULL

24542	NULL
IL-2-activated	NULL
transcription	NULL
factors	NULL
include	NULL
members	NULL
of	NULL
the	NULL
STAT	NULL
(	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
)	NULL
family	NULL
:	NULL
STAT3	NULL
and	NULL
STATS5	NULL
(	NULL
15-19	NULL
)	NULL
.	NULL

STAT	NULL
activation	NULL
involves	NULL
tyrosine	NULL
phosphorylation	NULL
which	NULL
allows	NULL
for	NULL
Sre	NULL
homology	NULL
(	NULL
SH	NULL
)	NULL
2	NULL
domain-mediated	NULL
homodimerization	NULL
or	NULL
heterodimerization	NULL
.	NULL

Activated	NULL
and	NULL
tyrosine-phosphorylated	NULL
STATs	NULL
then	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
to	NULL
form	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
complexes	NULL
and	NULL
enable	NULL
cytokine-mediated	NULL
gene	NULL
transcription	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

20	NULL
)	NULL
.	NULL

Serine	NULL
kinases	NULL
are	NULL
critical	NULL
for	NULL
STAT	NULL
activation	NULL
and	NULL
can	NULL
regulate	NULL
STAT	NULL
DNA	NULL
binding	NULL
or	NULL
transcriptional	NULL
activity	NULL
(	NULL
21-26	NULL
)	NULL
.	NULL

In	NULL
reconstitution	NULL
experiments	NULL
,	NULL
it	NULL
has	NULL
been	NULL
recently	NULL
shown	NULL
that	NULL
for	NULL
STATA	NULL
to	NULL
elicit	NULL
IFN-y-mediated	NULL
antigrowth	NULL
activity	NULL
,	NULL
the	NULL
serine	NULL
phosphorylation	NULL
site	NULL
(	NULL
Ser-727	NULL
)	NULL
is	NULL
required	NULL
(	NULL
27	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
recently	NULL
shown	NULL
that	NULL
IL-2	NULL
regulation	NULL
of	NULL
STATS	NULL
is	NULL
mediated	NULL
by	NULL
both	NULL
tyrosine	NULL
and	NULL
serine/threonine	NULL
kinase	NULL
pathways	NULL
(	NULL
28	NULL
)	NULL
.	NULL

STAT5	NULL
serine	NULL
phosphorylation	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
regulated	NULL
by	NULL
an	NULL
as	NULL
yet	NULL
uncharacterized	NULL
kinase	NULL
whose	NULL
activity	NULL
is	NULL
required	NULL
for	NULL
STATS	NULL
transcriptional	NULL
activity	NULL
.	NULL

IL-2	NULL
induces	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
DNA	NULL
binding	NULL
of	NULL
STAT3	NULL
.	NULL

The	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
in	NULL
the	NULL
STAT3	NULL
carboxyl	NULL
terminus	NULL
is	NULL
important	NULL
for	NULL
STAT3	NULL
transcriptional	NULL
function	NULL
,	NULL
but	NULL
neither	NULL
has	NULL
there	NULL
been	NULL
any	NULL
characterization	NULL
of	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
nor	NULL
any	NULL
study	NULL
of	NULL
the	NULL
identity	NULL
of	NULL
STAT3	NULL
serine	NULL
kinases	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Recent	NULL
debates	NULL
have	NULL
focused	NULL
particularly	NULL
on	NULL
the	NULL
role	NULL
of	NULL
MEK/ERK	NULL
kinase	NULL
pathways	NULL
in	NULL
STAT	NULL
activation	NULL
(	NULL
29	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
STAT3	NULL
serine	NULL
727	NULL
kinase	NULL
has	NULL
not	NULL
been	NULL
fully	NULL
resolved	NULL
in	NULL
any	NULL
cellular	NULL
system	NULL
.	NULL

This	NULL
site	NULL
forms	NULL
an	NULL
in	NULL
vitro	NULL
substrate	NULL
for	NULL
the	NULL
MAP	NULL
kinase	NULL
ERKs	NULL
which	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
STAT3	NULL
integrates	NULL
signals	NULL
from	NULL
the	NULL
MAP	NULL
kinases	NULL
.	NULL

This	NULL
hypothesis	NULL
has	NULL
not	NULL
been	NULL
fully	NULL
explored	NULL
in	NULL
vivo	NULL
,	NULL
in	NULL
particular	NULL
,	NULL
for	NULL
certain	NULL
cell	NULL
systems	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
is	NULL
constitutive	NULL
and	NULL
in	NULL
others	NULL
,	NULL
subject	NULL
to	NULL
regulation	NULL
by	NULL
extracellular	NULL
stimuli	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Herein	NULL
we	NULL
present	NULL
evidence	NULL
that	NULL
IL-2	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
DNA	NULL
binding	NULL
of	NULL
two	NULL
different	NULL
forms	NULL
of	NULL
STAT3	NULL
:	NULL
90-kDa	NULL
STAT3a	NULL
«	NULL
and	NULL
83-kDa	NULL
STAT3R	NULL
.	NULL

IL-2	NULL
also	NULL
induces	NULL
serine	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
in	NULL
STAT3a	NULL
via	NULL
a	NULL
MEK/ERK	NULL
pathway	NULL
.	NULL

The	NULL
present	NULL
data	NULL
also	NULL
show	NULL
that	NULL
STAT3	NULL
tyrosine	NULL
and	NULL
serine	NULL
phosphorylation	NULL
can	NULL
be	NULL
independently	NULL
regulated	NULL
:	NULL
activation	NULL
of	NULL
MAP	NULL
kinases	NULL
by	NULL
phorbol	NULL
esters	NULL
or	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
cross-linking	NULL
induces	NULL
phosphorylation	NULL
of	NULL
STAT3a	NULL
on	NULL
serine	NULL
727	NULL
without	NULL
concurrently	NULL
inducing	NULL
STAT3	NULL
DNA	NULL
binding	NULL
or	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

The	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
is	NULL
not	NULL
obligatory	NULL
for	NULL
DNA	NULL
binding	NULL
or	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
.	NULL

Nevertheless	NULL
,	NULL
we	NULL
find	NULL
a	NULL
H-7-sensitive	NULL
kinase	NULL
pathway	NULL
that	NULL
does	NULL
not	NULL
regulate	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
or	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
in	NULL
STAT3a	NULL
is	NULL
able	NULL
to	NULL
modulate	NULL
STAT3	NULL
DNA	NULL
binding	NULL
.	NULL

These	NULL
data	NULL
collectively	NULL
indicate	NULL
the	NULL
role	NULL
of	NULL
multiple	NULL
T	NULL
cell	NULL
signaling	NULL
pathways	NULL
in	NULL
mediating	NULL
differential	NULL
control	NULL
over	NULL
STAT	NULL
activation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Culture-Kit225	NULL
cells	NULL
(	NULL
80	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
1	NULL
nM	NULL
recombinant	NULL
IL-2	NULL
(	NULL
Eurocetus	NULL
)	NULL
.	NULL

IL-2	NULL
This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
STAT3	NULL
Regulation	NULL
in	NULL
T	NULL
Cells	NULL
receptor	NULL
expressing	NULL
human	NULL
peripheral	NULL
blood-derived	NULL
T	NULL
lymphoblasts	NULL
were	NULL
generated	NULL
and	NULL
maintained	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
81	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
quiesced	NULL
by	NULL
washing	NULL
three	NULL
times	NULL
in	NULL
RPMI	NULL
1640	NULL
,	NULL
and	NULL
replacing	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
10	NULL
%	NULL
serum	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
for	NULL
48-	NULL
72	NULL
h.	NULL
The	NULL
inhibitors	NULL
H-7	NULL
,	NULL
-	NULL
1-	NULL
(	NULL
G-isoquinolinylsulfonyl	NULL
)	NULL
-2-methylpiperazine	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
and	NULL
PDO098059	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
L.	NULL
O'Neill	NULL
,	NULL
Trinity	NULL
College	NULL
,	NULL
Dublin	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
cells	NULL
in	NULL
RPMI	NULL
1640	NULL
for	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
cytokine	NULL
stimulation	NULL
.	NULL

Recombinant	NULL
IL-2	NULL
(	NULL
1	NULL
nM	NULL
)	NULL
,	NULL
interferon	NULL
a	NULL
(	NULL
1000	NULL
units/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
or	NULL
phorbol	NULL
12,18-dibutyrate	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
was	NULL
incubated	NULL
at	NULL
indicated	NULL
times	NULL
.	NULL

Interferon	NULL
a	NULL
(	NULL
IFNa	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
I.	NULL
Kerr	NULL
.	NULL

Phorbol	NULL
12,13-dibutyrate	NULL
(	NULL
PDBu	NULL
)	NULL
was	NULL
from	NULL
Calbiochem	NULL
.	NULL

Affinity	NULL
Purification	NULL
of	NULL
DNA	NULL
and	NULL
Proteins-Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
lysis	NULL
of	NULL
approximately	NULL
10-20	NULL
x	NULL
10°	NULL
cells/ml	NULL
in	NULL
a	NULL
lysis	NULL
buffer	NULL
comprised	NULL
of	NULL
50	NULL
mM	NULL
Tris-Cl	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
mM	NULL
sodium	NULL
fluoride	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
;	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfony	NULL
]	NULL
!	NULL

fluoride	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
1	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
1	NULL
ug/ml	NULL
chymostatin	NULL
.	NULL

The	NULL
oligonucleotide	NULL
sequence	NULL
used	NULL
was	NULL
derived	NULL
from	NULL
the	NULL
high-affinity	NULL
SIE	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
(	NULL
SIEM6	NULL
?	NULL

7	NULL
)	NULL
GTCGACATTTCCCGTAAATC	NULL
.	NULL

DNA-binding	NULL
proteins	NULL
were	NULL
isolated	NULL
from	NULL
extracts	NULL
of	NULL
approximately	NULL
15	NULL
X	NULL
10°	NULL
cells	NULL
in	NULL
the	NULL
above	NULL
buffer	NULL
by	NULL
incubation	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
1	NULL
h	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
double-stranded	NULL
,	NULL
5'-biotinylated	NULL
oligonucleotide	NULL
coupled	NULL
to	NULL
30	NULL
ul	NULL
of	NULL
a	NULL
50	NULL
%	NULL
suspension	NULL
of	NULL
streptavidin-agarose	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

For	NULL
affinity	NULL
purification	NULL
of	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
phosphopeptide	NULL
IFNyR	NULL
Y440P	NULL
,	NULL
the	NULL
phosphotyrosylpeptide	NULL
TSFGYD-KPH	NULL
was	NULL
coupled	NULL
to	NULL
Affi-Gel	NULL
10	NULL
(	NULL
Bio-Rad	NULL
)	NULL
at	NULL
5	NULL
mg/ml	NULL
,	NULL
and	NULL
30	NULL
ul	NULL
were	NULL
used	NULL
to	NULL
purify	NULL
binding	NULL
proteins	NULL
from	NULL
1	NULL
ml	NULL
of	NULL
cell	NULL
lysate	NULL
.	NULL

Binding	NULL
was	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
complexes	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
lysis	NULL
buffer	NULL
prior	NULL
to	NULL
elution	NULL
by	NULL
boiling	NULL
in	NULL
reducing	NULL
sample	NULL
buffer	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
on	NULL
7.5	NULL
%	NULL
acrylamide	NULL
,	NULL
0.2	NULL
%	NULL
bis	NULL
gels	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
polyvinylidene	NULL
difluoride	NULL
membranes	NULL
(	NULL
Millipore	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
with	NULL
antibodies	NULL
to	NULL
phosphotyrosine	NULL
(	NULL
4G10	NULL
and	NULL
PY20	NULL
;	NULL
1	NULL
ug/ml	NULL
each	NULL
;	NULL
Upstate	NULL
Biotechnology	NULL
Inc.	NULL
and	NULL
Transduction	NULL
Laboratories	NULL
,	NULL
re-spectively	NULL
)	NULL
or	NULL
antibodies	NULL
against	NULL
STAT	NULL
proteins	NULL
;	NULL
STATS5	NULL
,	NULL
STAT3	NULL
,	NULL
or	NULL
STAT1	NULL
(	NULL
anti-ISGF3	NULL
)	NULL
(	NULL
Transduction	NULL
Laboratories	NULL
unless	NULL
indicated	NULL
other-wise	NULL
)	NULL
.	NULL

Immunoreactive	NULL
bands	NULL
were	NULL
visualized	NULL
with	NULL
the	NULL
epichemilumi-nescence	NULL
Western	NULL
blotting	NULL
system	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

For	NULL
the	NULL
analysis	NULL
of	NULL
STAT8	NULL
@	NULL
B	NULL
immunoreactivity	NULL
on	NULL
Western	NULL
blot	NULL
analyses	NULL
,	NULL
the	NULL
following	NULL
antibodies	NULL
were	NULL
used	NULL
:	NULL
amino-terminal	NULL
(	NULL
residues	NULL
1-175	NULL
)	NULL
raised	NULL
anti-STAT3	NULL
N-T	NULL
fusion	NULL
protein	NULL
,	NULL
carboxyl-terminal	NULL
(	NULL
residues	NULL
750-769	NULL
)	NULL
raised	NULL
anti-STAT3	NULL
C-T	NULL
peptide	NULL
,	NULL
and	NULL
carboxyl-terminal	NULL
(	NULL
residues	NULL
688-727	NULL
)	NULL
raised	NULL
anti-STAT3	NULL
C-T	NULL
fusion	NULL
protein	NULL
(	NULL
Transduction	NULL
Laboratories	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
,	NULL
and	NULL
a	NULL
gift	NULL
from	NULL
I.	NULL
Kerr	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

For	NULL
the	NULL
analysis	NULL
of	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
antibodies	NULL
raised	NULL
to	NULL
the	NULL
consensus	NULL
tyrosine	NULL
phosphorylation	NULL
motif	NULL
were	NULL
used	NULL
(	NULL
residues	NULL
701-709	NULL
)	NULL
;	NULL
either	NULL
using	NULL
a	NULL
tyrosine	NULL
phosphopeptide	NULL
(	NULL
a-Py	NULL
STAT3	NULL
)	NULL
or	NULL
the	NULL
equivalent	NULL
non-phosphorylated	NULL
peptide	NULL
(	NULL
a-STAT3	NULL
control	NULL
)	NULL
.	NULL

Both	NULL
antibodies	NULL
were	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
.	NULL

Generation	NULL
of	NULL
Phosphoserine	NULL
727	NULL
STAT3	NULL
Antisera-The	NULL
peptide	NULL
sequence	NULL
corresponding	NULL
to	NULL
human	NULL
STAT3	NULL
at	NULL
site	NULL
717-736	NULL
,	NULL
TC-SNTIDLPMSPRALDSLMQ	NULL
,	NULL
were	NULL
synthesized	NULL
with	NULL
serine	NULL
727	NULL
as	NULL
a	NULL
phosphopeptide	NULL
or	NULL
a	NULL
control	NULL
non-phosphorylated	NULL
peptide	NULL
.	NULL

These	NULL
peptides	NULL
were	NULL
then	NULL
coupled	NULL
to	NULL
keyhole	NULL
limpet	NULL
hemocyanin	NULL
via	NULL
the	NULL
glutar-aldehyde	NULL
coupling	NULL
method	NULL
.	NULL

Rabbit	NULL
antisera	NULL
to	NULL
these	NULL
serine	NULL
727	NULL
phosphopeptide	NULL
were	NULL
generated	NULL
by	NULL
standard	NULL
immunization	NULL
protocols	NULL
.	NULL

Rabbit	NULL
sera	NULL
was	NULL
screened	NULL
for	NULL
antigen	NULL
reactivity	NULL
by	NULL
standard	NULL
ELISA	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

On	NULL
final	NULL
screening	NULL
,	NULL
the	NULL
phosphoserine	NULL
727	NULL
antisera	NULL
was	NULL
used	NULL
at	NULL
a	NULL
dilution	NULL
of	NULL
1:5000	NULL
for	NULL
Western	NULL
analysis	NULL
and	NULL
at	NULL
a	NULL
dilution	NULL
of	NULL
1:100	NULL
for	NULL
immunoprecipitation	NULL
studies	NULL
.	NULL

Western	NULL
Blot	NULL
Analysis	NULL
of	NULL
Total	NULL
Cell	NULL
Lysates-Cells	NULL
were	NULL
lysed	NULL
in	NULL
the	NULL
buffer	NULL
used	NULL
for	NULL
affinity	NULL
purification	NULL
experiments	NULL
,	NULL
and	NULL
proteins	NULL
were	NULL
concentrated	NULL
by	NULL
precipitation	NULL
with	NULL
2.0	NULL
volumes	NULL
of	NULL
acetone	NULL
.	NULL

Proteins	NULL
isolated	NULL
from	NULL
1	NULL
to	NULL
3	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
using	NULL
the	NULL
following	NULL
gel	NULL
conditions	NULL
:	NULL
for	NULL
STATS5	NULL
,	NULL
STAT3	NULL
,	NULL
Sos	NULL
,	NULL
and	NULL
Raf-1	NULL
analysis	NULL
,	NULL
7.5	NULL
%	NULL
acrylamide	NULL
,	NULL
0.2	NULL
%	NULL
bisacrylamide	NULL
gels	NULL
and	NULL
15	NULL
%	NULL
acrylamide	NULL
,	NULL
0.075	NULL
%	NULL
bisacrylamide	NULL
for	NULL
MAP	NULL
kinase	NULL
analysis	NULL
.	NULL

Proteins	NULL
were	NULL
transferred	NULL
to	NULL
polyvinylidene	NULL
difluoride	NULL
membranes	NULL
,	NULL
and	NULL
detected	NULL
by	NULL
Western	NULL
blot	NULL
with	NULL
the	NULL
indicated	NULL
antisera	NULL
:	NULL
for	NULL
STATS5	NULL
and	NULL
STAT3	NULL
,	NULL
pan-Erk	NULL
antisera	NULL
(	NULL
Transduction	NULL
Labs	NULL
.	NULL
)	NULL

,	NULL
Sos	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
Inc.	NULL
)	NULL
,	NULL
Raf-1	NULL
(	NULL
Santa	NULL
Cruz	NULL
Inc.	NULL
)	NULL
,	NULL
or	NULL
phosphotyrosine	NULL
STAT3	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
,	NULL
unless	NULL
indicated	NULL
otherwise	NULL
.	NULL

RESULTS	NULL
IL-2	NULL
Induces	NULL
DNA	NULL
Binding	NULL
of	NULL
STAT3	NULL
«	NULL
and	NULL
STAT3B	NULL
in	NULL
T	NULL
Cells-Biotinylated	NULL
oligonucleotides	NULL
comprising	NULL
the	NULL
high-affinity	NULL
mutant	NULL
sis-inducible	NULL
element	NULL
(	NULL
SIEM	NULL
)	NULL
was	NULL
used	NULL
to	NULL
affinity	NULL
purify	NULL
STAT	NULL
proteins	NULL
from	NULL
cell	NULL
extracts	NULL
of	NULL
quiescent	NULL
or	NULL
IL-2-stimulated	NULL
human	NULL
peripheral	NULL
blood-derived	NULL
T	NULL
lymphoblasts	NULL
.	NULL

DNA	NULL
?	NULL

P	NULL
Ringing	NULL
SIEM	NULL
BLOT	NULL
IL-2	NULL
-	NULL
1	NULL
3	NULL
5°	NULL
10°	NULL
15	NULL
``	NULL
30°	NULL
60°	NULL
97	NULL
l	NULL
.-	NULL
ety	NULL
.-	NULL
sate	NULL
.	NULL

cm	NULL
a-STAT	NULL
5	NULL
68._I	NULL
97-1	NULL
~-	NULL
«	NULL
»	NULL
wes	NULL
OB	NULL
#	NULL
a	NULL
«	NULL
s	NULL
w-STAT	NULL
3	NULL
«	NULL
~	NULL
nere	NULL
cee	NULL
muse	NULL
68	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
[	NULL
Fotal	NULL
-	NULL
IFNyR	NULL
Total	NULL
|	NULL
IFNyR	NULL
[	NULL
Total	NULL
IFNyR	NULL
Sample	NULL
[	NULL
Lysate	NULL
Y440P	NULL
-	NULL
SIEM	NULL
-	NULL
[	NULL
Lysate	NULL
¥440P_	NULL
SIEM	NULL
[	NULL
Lysate	NULL
Y4s0P	NULL
-	NULL
SIEM	NULL
Mor	NULL
]	NULL
-	NULL
.	NULL

2	NULL
4	NULL
f.	NULL
.	NULL

2	NULL
oa	NULL
fpa	NULL
a	NULL
2	NULL
d	NULL
``	NULL
“	NULL
“	NULL
``	NULL
_	NULL
‘	NULL
:	NULL
;	NULL
``	NULL
1	NULL
``	NULL
_	NULL
{	NULL
'	NULL
_	NULL
:	NULL
:	NULL
_	NULL
“	NULL
1	NULL
N-T	NULL
fusion	NULL
protein	NULL
|	NULL
C-T	NULL
peptide	NULL
C-T	NULL
fusion	NULL
protein	NULL
wha	NULL
1-175	NULL
750	NULL
-	NULL
769	NULL
688	NULL
-	NULL
727	NULL
source	NULL
97=	NULL
cmap	NULL
«	NULL
ew	NULL
spam	NULL
B|	NULL
-sSTAT	NULL
30	NULL
«	NULL
--	NULL
Chip	NULL
dew	NULL
--	NULL
STAT	NULL
36	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

IL-2	NULL
induces	NULL
DNA	NULL
binding	NULL
of	NULL
two	NULL
distinct	NULL
forms	NULL
of	NULL
STAT3	NULL
.	NULL

A	NULL
,	NULL
IL-2-deprived	NULL
peripheral	NULL
blood-derived	NULL
T	NULL
lymphoblasts	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
stimulated	NULL
with	NULL
1	NULL
nM	NULL
IL-2	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
then	NULL
prepared	NULL
.	NULL

DNA-binding	NULL
proteins	NULL
were	NULL
affinity	NULL
purified	NULL
from	NULL
whole	NULL
cell	NULL
extracts	NULL
with	NULL
an	NULL
agarose-coupled	NULL
SIEM	NULL
oligonucleotide	NULL
.	NULL

Bound	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
detected	NULL
by	NULL
Western	NULL
blot	NULL
with	NULL
STAT5	NULL
or	NULL
STAT3	NULL
antibodies	NULL
.	NULL

B	NULL
,	NULL
Kit225	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
treated	NULL
for	NULL
10	NULL
min	NULL
with	NULL
IL-2	NULL
(	NULL
Zanes	NULL
4	NULL
,	NULL
8	NULL
,	NULL
and	NULL
12	NULL
)	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
acetone	NULL
precipitation	NULL
or	NULL
affinity	NULL
purification	NULL
with	NULL
tyrosine-phosphorylated	NULL
peptides	NULL
or	NULL
SIEM	NULL
oligonu-cleotides	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
antisera	NULL
raised	NULL
to	NULL
an	NULL
NH	NULL
,	NULL
-terminal	NULL
fusion	NULL
protein	NULL
(	NULL
Zanes	NULL
1-4	NULL
)	NULL
,	NULL
distal	NULL
COOH-terminal	NULL
peptide	NULL
(	NULL
residues	NULL
750-769	NULL
)	NULL
(	NULL
Zanes	NULL
5-8	NULL
)	NULL
,	NULL
or	NULL
antisera	NULL
generated	NULL
against	NULL
a	NULL
proximal	NULL
COOH-terminal	NULL
fusion	NULL
protein	NULL
(	NULL
residues	NULL
688-727	NULL
)	NULL
,	NULL
of	NULL
STAT3	NULL
(	NULL
lanes	NULL
9-12	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
molecular	NULL
weight	NULL
markers	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
in	NULL
kDa	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
show	NULL
that	NULL
IL-2	NULL
induces	NULL
DNA	NULL
binding	NULL
of	NULL
STAT3	NULL
and	NULL
STATS	NULL
in	NULL
peripheral	NULL
blood-derived	NULL
T	NULL
cells	NULL
.	NULL

IL-2	NULL
induced	NULL
DNA	NULL
binding	NULL
of	NULL
STAT3	NULL
and	NULL
STATS	NULL
is	NULL
clearly	NULL
discernible	NULL
within	NULL
1	NULL
min	NULL
of	NULL
exposure	NULL
to	NULL
the	NULL
cytokine	NULL
and	NULL
maximal	NULL
by	NULL
10	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

Two	NULL
forms	NULL
,	NULL
a	NULL
90-kDa	NULL
and	NULL
a	NULL
83-kDa	NULL
form	NULL
of	NULL
STAT3	NULL
proteins	NULL
,	NULL
were	NULL
seen	NULL
in	NULL
both	NULL
Kit225	NULL
cells	NULL
and	NULL
peripheral	NULL
blood-derived	NULL
T	NULL
lymphoblasts	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
not	NULL
noted	NULL
STAT3	NULL
heterogeneity	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
two	NULL
different	NULL
STAT3	NULL
proteins	NULL
of	NULL
90	NULL
and	NULL
83	NULL
kDa	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
IL-2	NULL
STAT-DNA	NULL
complexes	NULL
in	NULL
both	NULL
peripheral	NULL
blood-derived	NULL
T	NULL
cells	NULL
and	NULL
Kit225	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Two	NULL
different	NULL
forms	NULL
of	NULL
STAT3	NULL
have	NULL
been	NULL
described	NULL
:	NULL
STAT3a	NULL
«	NULL
and	NULL
STAT3R	NULL
;	NULL
STAT3R	NULL
being	NULL
a	NULL
carboxyl-terminal	NULL
truncated	NULL
spliced	NULL
variant	NULL
of	NULL
a	NULL
single	NULL
STAT3	NULL
gene	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
the	NULL
90-and	NULL
83-kDa	NULL
IL-2	NULL
induced	NULL
STAT3	NULL
proteins	NULL
(	NULL
termed	NULL
hereafter	NULL
as	NULL
STAT3a	NULL
«	NULL
and	NULL
STAT3	NULL
$	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
antisera	NULL
raised	NULL
against	NULL
different	NULL
domains	NULL
of	NULL
STAT3	NULL
were	NULL
used	NULL
in	NULL
Western	NULL
blot	NULL
analyses	NULL
of	NULL
the	NULL
STAT3	NULL
proteins	NULL
in	NULL
total	NULL
T	NULL
cell	NULL
lysates	NULL
and	NULL
in	NULL
DNA	NULL
binding	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
a	NULL
tyrosine	NULL
phosphopeptide	NULL
comprising	NULL
the	NULL
tyrosine-phosphorylation	NULL
site	NULL
(	NULL
Tyr-440	NULL
)	NULL
of	NULL
the	NULL
y-interferon	NULL
receptor	NULL
«	NULL
-chain	NULL
was	NULL
used	NULL
to	NULL
generate	NULL
an	NULL
affinity	NULL
matrix	NULL
for	NULL
the	NULL
purification	NULL
of	NULL
STAT3	NULL
from	NULL
cell	NULL
ex-tracts	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
show	NULL
that	NULL
antisera	NULL
raised	NULL
against	NULL
an	NULL
STAT3	NULL
fusion	NULL
protein	NULL
and	NULL
antisera	NULL
generated	NULL
against	NULL
a	NULL
fusion	NULL
protein	NULL
comprising	NULL
residues	NULL
688-727	NULL
of	NULL
STAT3	NULL
recognize	NULL
two	NULL
STAT3	NULL
proteins	NULL
in	NULL
T	NULL
cell	NULL
lysates	NULL
and	NULL
in	NULL
the	NULL
Tyr-440	NULL
peptide	NULL
complexes	NULL
.	NULL

They	NULL
also	NULL
recognize	NULL
both	NULL
IL-2-induced	NULL
STAT3	NULL
proteins	NULL
in	NULL
SIEM	NULL
DNA	NULL
binding	NULL
complexes	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
antisera	NULL
raised	NULL
against	NULL
a	NULL
COOH-terminal	NULL
STAT3	NULL
peptide	NULL
comprising	NULL
residues	NULL
750-769	NULL
recognize	NULL
only	NULL
the	NULL
90	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
24544	NULL
LP	NULL
.	NULL

|	NULL
a-STAT3	NULL
C-T	NULL
peptide	NULL
Ligand	NULL
|	NULL
_	NULL
_	NULL
mp9	NULL
rFm	NULL
'	NULL
-	NULL
_	NULL
IL-2	NULL
IFNocl	NULL
-_	NULL
IL-2	NULL
IFNa_	NULL
~	NULL
@	NULL
000	NULL
«	NULL
wan	NULL
.	NULL

cts	NULL
.	NULL

CP	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
j	NULL
_S	NULL
9	NULL
BLOT	NULL
3	NULL
-	NULL
e-STATS5	NULL
STAT3	NULL
N-T	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
is	NULL
detected	NULL
using	NULL
phosphotyrosine	NULL
(	NULL
Tyr	NULL
(	NULL
P	NULL
)	NULL
-705	NULL
)	NULL
STATS	NULL
antibodies	NULL
in	NULL
IL-2	NULL
and	NULL
interferon	NULL
a-treated	NULL
cells	NULL
.	NULL

Total	NULL
lysates	NULL
were	NULL
prepared	NULL
from	NULL
unstimu-lated	NULL
(	NULL
Zanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
and	NULL
7	NULL
)	NULL
,	NULL
IL-2	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
8	NULL
)	NULL
,	NULL
or	NULL
interferon	NULL
a	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
9	NULL
)	NULL
-treated	NULL
Kit225	NULL
cells	NULL
and	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
using	NULL
an	NULL
antibody	NULL
raised	NULL
to	NULL
residues	NULL
(	NULL
750-769	NULL
)	NULL
of	NULL
STAT3	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
with	NULL
phosphotyrosine	NULL
(	NULL
Tyr	NULL
(	NULL
P	NULL
)	NULL
-705	NULL
)	NULL
STAT3	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
,	NULL
STATS	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
,	NULL
and	NULL
STATS	NULL
(	NULL
Zanes	NULL
7-9	NULL
)	NULL
antibodies	NULL
.	NULL

kDa	NULL
STAT3	NULL
and	NULL
not	NULL
the	NULL
83-kDa	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
83-kDa	NULL
STAT3B	NULL
protein	NULL
in	NULL
T	NULL
cells	NULL
thus	NULL
corresponds	NULL
to	NULL
the	NULL
recently	NULL
described	NULL
carboxyl-terminal	NULL
truncated	NULL
spliced	NULL
variant	NULL
of	NULL
STAT3	NULL
(	NULL
82	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Activated	NULL
and	NULL
tyrosine	NULL
phosphorylated	NULL
STAT	NULL
proteins	NULL
were	NULL
readily	NULL
detected	NULL
in	NULL
STAT3	NULL
immunoprecipitates	NULL
prepared	NULL
from	NULL
IL-2	NULL
activated	NULL
T	NULL
cells	NULL
using	NULL
anti-phosphoty-rosine	NULL
antibodies	NULL
raised	NULL
to	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
site	NULL
of	NULL
STAT3	NULL
(	NULL
Tyr-705	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

IL-2	NULL
Induces	NULL
Phosphorylation	NULL
of	NULL
Serine	NULL
727	NULL
in	NULL
STAT3o-There	NULL
was	NULL
a	NULL
discernible	NULL
reduction	NULL
in	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
STAT3a	NULL
but	NULL
not	NULL
STAT3B	NULL
isolated	NULL
from	NULL
IL-2-activated	NULL
Kit225	NULL
cells	NULL
and	NULL
in	NULL
IL-2	NULL
activated	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphoblasts	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Both	NULL
forms	NULL
of	NULL
STAT3	NULL
«	NULL
(	NULL
termed	NULL
s	NULL
,	NULL
slow	NULL
,	NULL
and	NULL
f	NULL
,	NULL
fast	NULL
;	NULL
for	NULL
the	NULL
different	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
properties	NULL
)	NULL
can	NULL
equally	NULL
bind	NULL
DNA	NULL
upon	NULL
IL-2	NULL
activation	NULL
and	NULL
are	NULL
both	NULL
tyrosine-phosphorylated	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
STAT3a	NULL
to	NULL
undergo	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
could	NULL
reflect	NULL
IL-2-regulated	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
.	NULL

There	NULL
is	NULL
a	NULL
serine	NULL
phosphorylation	NULL
site	NULL
at	NULL
residue	NULL
727	NULL
in	NULL
STAT3a	NULL
that	NULL
is	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Generation	NULL
of	NULL
phosphorylation	NULL
state-specific	NULL
antibodies	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
34	NULL
)	NULL
and	NULL
had	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
successful	NULL
in	NULL
the	NULL
analysis	NULL
of	NULL
site-specific	NULL
phospho-rylations	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
proteins	NULL
(	NULL
85-37	NULL
)	NULL
,	NULL
including	NULL
transcription	NULL
factors	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Thus	NULL
to	NULL
circumvent	NULL
radiolabeling	NULL
techniques	NULL
and	NULL
to	NULL
explore	NULL
whether	NULL
IL-2	NULL
is	NULL
inducing	NULL
the	NULL
phosphorylation	NULL
of	NULL
STAT3a	NULL
on	NULL
serine	NULL
727	NULL
,	NULL
we	NULL
generated	NULL
rabbit	NULL
antisera	NULL
selectively	NULL
reactive	NULL
to	NULL
a	NULL
phosphopeptide	NULL
corresponding	NULL
to	NULL
the	NULL
serine	NULL
727	NULL
site	NULL
in	NULL
STAT3	NULL
.	NULL

The	NULL
selectivity	NULL
of	NULL
this	NULL
antisera	NULL
for	NULL
the	NULL
phosphorylated	NULL
serine	NULL
727	NULL
STAT3	NULL
peptide	NULL
compared	NULL
with	NULL
the	NULL
nonphosphorylated	NULL
peptide	NULL
is	NULL
shown	NULL
by	NULL
ELISA	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

The	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
antisera	NULL
could	NULL
weakly	NULL
immu-noprecipitate	NULL
STAT3a	NULL
proteins	NULL
from	NULL
quiescent	NULL
peripheral	NULL
blood-derived	NULL
T	NULL
cells	NULL
but	NULL
levels	NULL
of	NULL
STAT3	NULL
«	NULL
immunoprecipitable	NULL
with	NULL
the	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
antisera	NULL
were	NULL
increased	NULL
markedly	NULL
in	NULL
cells	NULL
lysates	NULL
isolated	NULL
from	NULL
IL-2	NULL
stimulated	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

The	NULL
carboxyl-terminal	NULL
truncated	NULL
STAT3B	NULL
protein	NULL
lacking	NULL
the	NULL
serine	NULL
727	NULL
site	NULL
could	NULL
not	NULL
be	NULL
immunoprecipitated	NULL
with	NULL
the	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
antisera	NULL
from	NULL
either	NULL
quiescent	NULL
or	NULL
IL-2-activated	NULL
cells	NULL
.	NULL

On	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
IL-2	NULL
induced	NULL
STAT3a	NULL
DNA	NULL
bound	NULL
proteins	NULL
were	NULL
also	NULL
reactive	NULL
with	NULL
the	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
antisera	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

The	NULL
reactivity	NULL
of	NULL
the	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
antisera	NULL
with	NULL
STATS3a	NULL
«	NULL
proteins	NULL
isolated	NULL
from	NULL
IL-2-activated	NULL
T	NULL
cells	NULL
could	NULL
be	NULL
blocked	NULL
by	NULL
competition	NULL
with	NULL
the	NULL
phosphorylated	NULL
serine	NULL
727	NULL
STAT3	NULL
peptide	NULL
STAT3	NULL
Regulation	NULL
in	NULL
T	NULL
Cells	NULL
A	NULL
Total	NULL
s	NULL
Lysate	NULL
Kit	NULL
225	NULL
SLOT	NULL
IL-2	NULL
=	NULL
+	NULL
97	NULL
-|	NULL
/	NULL
STAT	NULL
3a	NULL
s	NULL
1h	NULL
®	NULL
STAT	NULL
3a	NULL
f	NULL
a-STAT3	NULL
STAT	NULL
38	NULL
68	NULL
1	NULL
2	NULL
B	NULL
2.000	NULL
h	NULL
-	NULL
#	NULL
-	NULL
_	NULL
STAT3	NULL
pS	NULL
727	NULL
g	NULL
1.500	NULL
-	NULL
``	NULL
-o-	NULL
-	NULL
STATE	NULL
717-736	NULL
E	NULL
tel	NULL
Co	NULL
=F	NULL
Q	NULL
&	NULL
§	NULL
-	NULL
1000	NULL
82	NULL
o	NULL
t	NULL
G	NULL
-f	NULL
0.500	NULL
``	NULL
``	NULL
``	NULL
T	NULL
fqn	NULL
fg	NULL
.	NULL

fy	NULL
...	NULL
fe	NULL
frm	NULL
0.000	NULL
-	NULL
-	NULL
f	NULL
f	NULL
t	NULL
100	NULL
1000	NULL
10000	NULL
100000	NULL
1000000	NULL
Antibody	NULL
dilution	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

A	NULL
,	NULL
IL-2	NULL
induces	NULL
STATS8	NULL
@	NULL
hyperphosphorylation	NULL
.	NULL

Kit225	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
,	NULL
or	NULL
stimulated	NULL
with	NULL
1	NULL
nM	NULL
IL-2	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
proteins	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
with	NULL
STAT3	NULL
antibodies	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
molecular	NULL
weight	NULL
markers	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
lef	NULL
?	NULL

in	NULL
kDa	NULL
.	NULL

B	NULL
,	NULL
ELISA	NULL
immunoreactivity	NULL
of	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
antibody	NULL
microtiter	NULL
plates	NULL
were	NULL
coated	NULL
with	NULL
2.5	NULL
pmol	NULL
of	NULL
the	NULL
STAT3	NULL
immunizing	NULL
peptide	NULL
717-786	NULL
,	NULL
as	NULL
a	NULL
phosphoserine	NULL
peptide	NULL
(	NULL
filled	NULL
circles	NULL
)	NULL
or	NULL
non-phosphorylated	NULL
peptide	NULL
(	NULL
open	NULL
triangles	NULL
)	NULL
,	NULL
and	NULL
subsequently	NULL
blocked	NULL
with	NULL
gelatin	NULL
.	NULL

Antisera	NULL
was	NULL
then	NULL
incubated	NULL
at	NULL
the	NULL
indicated	NULL
dilutions	NULL
,	NULL
starting	NULL
at	NULL
1:100	NULL
,	NULL
followed	NULL
with	NULL
serial	NULL
2-fold	NULL
dilutions	NULL
.	NULL

Horseradish	NULL
peroxidase-linked	NULL
donkey	NULL
anti-rabbit	NULL
antisera	NULL
was	NULL
then	NULL
incubated	NULL
at	NULL
1:1000	NULL
.	NULL

Plates	NULL
were	NULL
subsequently	NULL
washed	NULL
in	NULL
phosphate-buffered	NULL
saline-Tween	NULL
0.05	NULL
%	NULL
and	NULL
immunoabsorbance	NULL
was	NULL
detected	NULL
using	NULL
ABTS	NULL
substrate	NULL
(	NULL
Boeh-ringer	NULL
Mannheim	NULL
)	NULL
.	NULL

Plates	NULL
were	NULL
read	NULL
at	NULL
405	NULL
nm	NULL
after	NULL
30	NULL
min	NULL
incubation	NULL
.	NULL

Data	NULL
shown	NULL
represents	NULL
two	NULL
such	NULL
experiments	NULL
expressed	NULL
as	NULL
an	NULL
average	NULL
.	NULL

but	NULL
not	NULL
the	NULL
nonphosphorylated	NULL
peptide	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

STAT3	NULL
proteins	NULL
,	NULL
affinity	NULL
purified	NULL
using	NULL
the	NULL
IFNyR	NULL
Tyr-440	NULL
tyrosine	NULL
phosphopeptide	NULL
matrix	NULL
were	NULL
similarily	NULL
analyzed	NULL
for	NULL
immunoreactivity	NULL
with	NULL
the	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
antisera	NULL
.	NULL

There	NULL
was	NULL
a	NULL
low	NULL
level	NULL
reactivity	NULL
of	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
antisera	NULL
with	NULL
STAT3	NULL
proteins	NULL
isolated	NULL
from	NULL
quiescent	NULL
cells	NULL
but	NULL
this	NULL
was	NULL
markedly	NULL
increased	NULL
upon	NULL
IL-2	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

No	NULL
reactivity	NULL
of	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
antisera	NULL
with	NULL
STAT3RB	NULL
could	NULL
be	NULL
detected	NULL
.	NULL

These	NULL
data	NULL
collectively	NULL
show	NULL
that	NULL
IL-2	NULL
induces	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
«	NULL
on	NULL
serine	NULL
727	NULL
in	NULL
peripheral	NULL
blood-derived	NULL
T	NULL
lymphoblasts	NULL
.	NULL

Serine	NULL
727	NULL
in	NULL
STAT3	NULL
«	NULL
Is	NULL
Regulated	NULL
by	NULL
the	NULL
MEK/ERK	NULL
Pathway	NULL
in	NULL
T	NULL
Cells-Xenopus	NULL
MAP	NULL
kinase	NULL
can	NULL
phosphorylate	NULL
STAT1	NULL
in	NULL
vitro	NULL
at	NULL
the	NULL
carboxyl	NULL
terminus	NULL
consensus	NULL
MAPK	NULL
phosphorylation	NULL
site	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
equivalent	NULL
in	NULL
vitro	NULL
ERK	NULL
site	NULL
in	NULL
STAT3	NULL
is	NULL
serine	NULL
727	NULL
.	NULL

To	NULL
explore	NULL
directly	NULL
the	NULL
role	NULL
of	NULL
the	NULL
MEK/	NULL
ERK	NULL
pathway	NULL
in	NULL
STAT3	NULL
regulation	NULL
by	NULL
IL-2	NULL
we	NULL
used	NULL
an	NULL
inhibitor	NULL
of	NULL
the	NULL
ERK	NULL
stimulatory	NULL
kinase	NULL
,	NULL
MAP	NULL
kinase	NULL
kinase	NULL
(	NULL
MEK	NULL
)	NULL
,	NULL
PDO098059	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
PDO98059	NULL
as	NULL
a	NULL
MEK	NULL
inhibitor	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
89	NULL
,	NULL
40	NULL
)	NULL
.	NULL

To	NULL
monitor	NULL
the	NULL
effectiveness	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
STAT3	NULL
Regulation	NULL
in	NULL
T	NULL
Cells	NULL
A	NULL
1p	NULL
.	NULL

-STAT3	NULL
``	NULL
*	NULL
_	NULL
pS727	NULL
Ligand	NULL
~	NULL
IL-2	NULL
97	NULL
-I	NULL
68	NULL
_|	NULL
1	NULL
2	NULL
BLOT	NULL
o-STAT3	NULL
B	NULL
Binding	NULL
SIEM	NULL
Ligand	NULL
=-	NULL
IL-2	NULL
--	NULL
IL-2	NULL
=	NULL
--	NULL
IL-2	NULL
97	NULL
97	NULL
-|	NULL
97	NULL
-	NULL
.	NULL

STAT	NULL
3	NULL
<	NULL
--	NULL
STAT	NULL
3	NULL
f-	NULL
@	NULL
a	NULL
*	NULL
STAT	NULL
ag	NULL
i	NULL
«	NULL
+	NULL
gon	NULL
|	NULL
<	NULL
-	NULL
STAT	NULL
38	NULL
68	NULL
68	NULL
68	NULL
_|	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
BLOT	NULL
-	NULL
y-STAT3	NULL
a	NULL
«	NULL
-STAT3	NULL
a-pY	NULL
STAT	NULL
pS	NULL
727	NULL
Binding	NULL
IFNyR	NULL
Y440P	NULL
Ligand	NULL
--	NULL
IL-2	NULL
--	NULL
IL-2	NULL
97	NULL
-	NULL
]	NULL
97	NULL
th	NULL
#	NULL
2	NULL
68	NULL
68	NULL
1	NULL
2	NULL
3	NULL
4	NULL
BLOT	NULL
-	NULL
a-STAT3pS	NULL
727	NULL
o-STAT3	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

IL-2	NULL
induces	NULL
the	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
in	NULL
STAT3	NULL
«	NULL
.	NULL

A	NULL
,	NULL
quiescent	NULL
human	NULL
T	NULL
lymphoblasts	NULL
were	NULL
untreated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
IL-2	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
(	NULL
LP	NULL
.	NULL
)	NULL

using	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
antisera	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
followed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
STAT3	NULL
antibodies	NULL
.	NULL

B	NULL
,	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
above	NULL
and	NULL
DNA	NULL
bound	NULL
proteins	NULL
were	NULL
affinity	NULL
purified	NULL
with	NULL
SIEM	NULL
oligonucleotides	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
on	NULL
SDS-PAGE	NULL
and	NULL
STAT	NULL
proteins	NULL
were	NULL
detected	NULL
using	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
STAT3	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
or	NULL
phosphotyrosine	NULL
(	NULL
Tyr	NULL
(	NULL
P	NULL
)	NULL
-705	NULL
)	NULL
STAT3	NULL
antibodies	NULL
(	NULL
Zanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

In	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
phosphotyrosine	NULL
STAT3	NULL
antibodies	NULL
were	NULL
cross-reactive	NULL
with	NULL
tyrosine-phosphorylated	NULL
STAT5	NULL
,	NULL
hence	NULL
indicated	NULL
as	NULL
a-phosphotyrosine	NULL
(	NULL
a-p¥	NULL
)	NULL
STAT	NULL
.	NULL

C	NULL
,	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
above	NULL
and	NULL
STAT	NULL
proteins	NULL
were	NULL
affinity	NULL
purified	NULL
using	NULL
agarose-conjugated	NULL
tyrosine	NULL
phosphopeptides	NULL
,	NULL
as	NULL
previously	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
on	NULL
SDS-PAGE	NULL
and	NULL
followed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
STAT3	NULL
antibodies	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

of	NULL
the	NULL
MEK	NULL
inhibitor	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
phosphorylation	NULL
of	NULL
ERK	NULL
induced	NULL
by	NULL
IL-2	NULL
in	NULL
T	NULL
cells	NULL
pretreated	NULL
with	NULL
PD098059	NULL
.	NULL

As	NULL
an	NULL
additional	NULL
means	NULL
to	NULL
monitor	NULL
ERK	NULL
activation	NULL
in	NULL
IL-2-treated	NULL
cells	NULL
,	NULL
hyperphosphorylation	NULL
of	NULL
ERK	NULL
substrates	NULL
were	NULL
also	NULL
analyzed	NULL
.	NULL

Cellular	NULL
substrates	NULL
for	NULL
ERK	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
as	NULL
in	NULL
many	NULL
cells	NULL
,	NULL
include	NULL
the	NULL
p21	NULL
``	NULL
effector	NULL
molecule	NULL
Raf-1	NULL
,	NULL
and	NULL
the	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
protein	NULL
Sos	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

These	NULL
proteins	NULL
are	NULL
both	NULL
upstream	NULL
regulators	NULL
of	NULL
the	NULL
MAP	NULL
kinases	NULL
,	NULL
but	NULL
are	NULL
phosphorylated	NULL
by	NULL
the	NULL
MAP	NULL
kinases	NULL
through	NULL
feedback	NULL
signaling	NULL
mechanisms	NULL
.	NULL

Hyperphosphorylated	NULL
ERK	NULL
,	NULL
Raf-1	NULL
,	NULL
and	NULL
Sos	NULL
have	NULL
reduced	NULL
electrophoretic	NULL
mobility	NULL
when	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
show	NULL
that	NULL
IL-2	NULL
regulated	NULL
hyperphosphorylation	NULL
of	NULL
ERK	NULL
,	NULL
Sos	NULL
,	NULL
and	NULL
Raf-1	NULL
are	NULL
inhibited	NULL
by	NULL
the	NULL
24545	NULL
A	NULL
IL2	NULL
_|	NULL
-	NULL
}	NULL
0	NULL
+	NULL
|	NULL
BLOT	NULL
mz	NULL
|	NULL
.	NULL

.	NULL

.	NULL

|	NULL
stor	NULL
PD	NULL
z	NULL
-	NULL
R	NULL
Po	NULL
-	NULL
y-4	NULL
***	NULL
awaap	NULL
«	NULL
aid	NULL
GBD	NULL
)	NULL
c-	NULL
pan	NULL
ERK	NULL
a-	NULL
sos	NULL
tin	NULL
o-	NULL
raf-1	NULL
B	NULL
DNA	NULL
binding	NULL
|	NULL
SIEM	NULL
IL-2	NULL
oe	NULL
BLOT	NULL
PD	NULL
-	NULL
-	NULL
£	NULL
97	NULL
-	NULL
ar	NULL
___	NULL
o-	NULL
STAT	NULL
3	NULL
T	NULL
--	NULL
-STAT	NULL
3a	NULL
f	NULL
a-	NULL
STAT	NULL
3B	NULL
68	NULL
1	NULL
2	NULL
3	NULL
C	NULL
Binding	NULL
-	NULL
IFNyR	NULL
Y¥440	NULL
P	NULL
Ligand	NULL
z	NULL
IL-2	NULL
IL-2	NULL
PD	NULL
098059	NULL
-	NULL
-	NULL
-	NULL
_	NULL
+	NULL
97-hermes	NULL
I	NULL
wn	NULL
68	NULL
1	NULL
2	NULL
3	NULL
BLOT	NULL
o-STAT3	NULL
pS	NULL
727	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
MEK	NULL
inactivation	NULL
on	NULL
IL-2/STAT	NULL
regulation	NULL
.	NULL

A	NULL
,	NULL
Kit225	NULL
cells	NULL
were	NULL
untreated	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
IL-2	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
for	NULL
10	NULL
min	NULL
following	NULL
a	NULL
80-min	NULL
preincubation	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
of	NULL
PDO98059	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
acetone	NULL
precipitated	NULL
as	NULL
above	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
using	NULL
MAPK	NULL
(	NULL
ERK	NULL
)	NULL
,	NULL
Raf-1	NULL
,	NULL
and	NULL
Sos	NULL
antibodies	NULL
(	NULL
as	NULL
indicated	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Kit225	NULL
cells	NULL
were	NULL
untreated	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
IL-2	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
for	NULL
10	NULL
min	NULL
following	NULL
a	NULL
30-min	NULL
preincubation	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
of	NULL
PDO98059	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
SIEM-binding	NULL
proteins	NULL
were	NULL
affinity	NULL
purified	NULL
and	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
blot	NULL
using	NULL
STAT3	NULL
antibodies	NULL
.	NULL

C	NULL
,	NULL
Kit225	NULL
cells	NULL
were	NULL
treated	NULL
as	NULL
above	NULL
and	NULL
STAT	NULL
proteins	NULL
were	NULL
affinity	NULL
purified	NULL
using	NULL
agarose-conjugated	NULL
tyrosine	NULL
phosphopep-tide	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
on	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
Western	NULL
analysis	NULL
using	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
.	NULL

MEK	NULL
inhibitor	NULL
PDO98059	NULL
,	NULL
demonstrating	NULL
that	NULL
this	NULL
inhibitor	NULL
is	NULL
effective	NULL
at	NULL
blocking	NULL
the	NULL
MEK/ERK	NULL
pathway	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Analysis	NULL
of	NULL
STAT3a	NULL
«	NULL
and	NULL
STAT3	NULL
$	NULL
in	NULL
DNA	NULL
bound	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
shows	NULL
that	NULL
IL-2	NULL
induced	NULL
changes	NULL
in	NULL
STAT3a	NULL
electrophoretic	NULL
mobility	NULL
were	NULL
inhibited	NULL
by	NULL
the	NULL
MEK	NULL
inhibitor	NULL
PDO98059	NULL
,	NULL
however	NULL
,	NULL
this	NULL
inhibitor	NULL
did	NULL
not	NULL
prevent	NULL
IL-2	NULL
induced	NULL
DNA	NULL
binding	NULL
of	NULL
STAT3	NULL
.	NULL

To	NULL
examine	NULL
directly	NULL
the	NULL
effects	NULL
of	NULL
PDO98059	NULL
on	NULL
IL-2	NULL
induced	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
of	NULL
STAT3a	NULL
@	NULL
we	NULL
used	NULL
the	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
antisera	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
shows	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
reactivity	NULL
of	NULL
the	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
antisera	NULL
with	NULL
STAT3	NULL
«	NULL
@	NULL
,	NULL
isolated	NULL
from	NULL
IL-2-activated	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
increased	NULL
reactivity	NULL
was	NULL
inhibited	NULL
in	NULL
STAT3	NULL
«	NULL
proteins	NULL
isolated	NULL
from	NULL
IL-2-treated	NULL
T	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
preincubated	NULL
with	NULL
the	NULL
MEK	NULL
inhibitor	NULL
PDO098059	NULL
.	NULL

Hence	NULL
,	NULL
inhibition	NULL
of	NULL
the	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
24546	NULL
A	NULL
IL-2	NULL
>	NULL
-	NULL
+	NULL
BLOT	NULL
PDBu	NULL
=	NULL
+00	NULL
_-977	NULL
+-	NULL
STAT	NULL
5p2	NULL
amas	NULL
(	NULL
.	NULL

5	NULL
-STAT	NULL
5	NULL
6s	NULL
_L	NULL
.	NULL

977	NULL
oe	NULL
meee	NULL
|-	NULL
Si	NULL
.	NULL

:	NULL
oc	NULL
;	NULL
=	NULL
O-STAT	NULL
3	NULL
+	NULL
--	NULL
-STAT	NULL
38	NULL
68g	NULL
10	NULL
1	NULL
2	NULL
3	NULL
B	NULL
A	NULL
Ligand	NULL
-	NULL
IL-2	NULL
PDBu	NULL
--	NULL
IL-2	NULL
PDBu	NULL
97	NULL
``	NULL
|	NULL
_|	NULL
«	NULL
=	NULL
--	NULL
<	NULL
--	NULL
STAT	NULL
38	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
BLOT	NULL
«	NULL
-STAT3	NULL
a-STAT3	NULL
pS	NULL
727	NULL
i	NULL
STAT	NULL
O-	NULL
3	NULL
LP	NULL
.	NULL

pS	NULL
727	NULL
Ligand	NULL
|	NULL
.	NULL

ts	NULL
PDBu	NULL
97	NULL
e	NULL
«	NULL
s	NULL
Gas	NULL
68	NULL
1	NULL
2	NULL
3	NULL
BLOT	NULL
a-STAT3	NULL
C	NULL
DNA	NULL
binding	NULL
|	NULL
SIEM	NULL
IL-2	NULL
s	NULL
x	NULL
L	NULL
BLOT	NULL
PDBu	NULL
+	NULL
=	NULL
977	NULL
STAT	NULL
5p2	NULL
*	NULL
*I*	NULL
-	NULL
<	NULL
graAT	NULL
5p1	NULL
x-STAT	NULL
5	NULL
68	NULL
_|	NULL
97-4	NULL
*~	NULL
STAT	NULL
30	NULL
-STAT	NULL
3	NULL
*-	NULL
STAT	NULL
3B	NULL
68	NULL
_	NULL
e	NULL
1	NULL
2	NULL
3	NULL
D	NULL
Binding	NULL
IENyR	NULL
Y440P	NULL
Ligand	NULL
z	NULL
IL-2	NULL
-	NULL
UCHT-1	NULL
UCHTA	NULL
PD	NULL
098059	NULL
.	NULL

s	NULL
=	NULL
+	NULL
97	NULL
o	NULL
cme	NULL
—	NULL
--	NULL
-ss	NULL
L_	NULL
aude	NULL
galas	NULL
)	NULL
1	NULL
2	NULL
3	NULL
4	NULL
BLOT	NULL
o-STAT3	NULL
pS	NULL
727	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Effects	NULL
of	NULL
PDBu	NULL
and	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
agonist	NULL
UCHT-1	NULL
on	NULL
STATS	NULL
.	NULL

A	NULL
,	NULL
Kit225	NULL
cells	NULL
were	NULL
untreated	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
,	NULL
stimulated	NULL
STAT3	NULL
Regulation	NULL
in	NULL
T	NULL
Cells	NULL
MEK/ERK	NULL
pathway	NULL
prevents	NULL
the	NULL
IL-2-induced	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
in	NULL
STAT3	NULL
@	NULL
.	NULL

The	NULL
Induction	NULL
of	NULL
STAT3a	NULL
Phosphorylation	NULL
on	NULL
Serine	NULL
727	NULL
Does	NULL
Not	NULL
Require	NULL
Tyrosine	NULL
Phosphorylation	NULL
of	NULL
STAT3a-The	NULL
phorbol	NULL
ester	NULL
PDBu	NULL
stimulates	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
activates	NULL
the	NULL
ERK/MAP	NULL
kinase	NULL
pathway	NULL
independently	NULL
of	NULL
IL-2	NULL
receptor	NULL
activation	NULL
.	NULL

If	NULL
STAT3	NULL
«	NULL
is	NULL
regulated	NULL
by	NULL
MEK/ERK	NULL
then	NULL
one	NULL
possibility	NULL
is	NULL
that	NULL
PDBu	NULL
,	NULL
which	NULL
activates	NULL
ERK	NULL
via	NULL
a	NULL
protein	NULL
kinase	NULL
C/Raf-1	NULL
pathway	NULL
independent	NULL
of	NULL
IL-2	NULL
,	NULL
could	NULL
also	NULL
induce	NULL
the	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
in	NULL
STAT3a	NULL
@	NULL
.	NULL

This	NULL
is	NULL
assuming	NULL
that	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
proteins	NULL
can	NULL
proceed	NULL
independently	NULL
of	NULL
their	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
show	NULL
that	NULL
PDBu	NULL
did	NULL
not	NULL
induce	NULL
changes	NULL
in	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
STATS	NULL
but	NULL
similar	NULL
to	NULL
IL-2	NULL
,	NULL
PDBu	NULL
induced	NULL
changes	NULL
in	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
STATS3	NULL
«	NULL
but	NULL
not	NULL
STAT3B	NULL
.	NULL

Moreover	NULL
,	NULL
immunoprecipitation	NULL
and	NULL
Western	NULL
blot	NULL
analyses	NULL
of	NULL
STAT3	NULL
proteins	NULL
showed	NULL
that	NULL
PDBu	NULL
induced	NULL
STAT3a	NULL
reactivity	NULL
with	NULL
the	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
antisera	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
panels	NULL
a	NULL
and	NULL
b	NULL
)	NULL
.	NULL

PDBu	NULL
did	NULL
not	NULL
induce	NULL
DNA	NULL
binding	NULL
of	NULL
STAT3	NULL
probably	NULL
because	NULL
of	NULL
the	NULL
failure	NULL
of	NULL
phorbol	NULL
esters	NULL
to	NULL
induce	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
PDBu	NULL
data	NULL
thus	NULL
show	NULL
that	NULL
phosphorylation	NULL
of	NULL
STAT3a	NULL
on	NULL
serine	NULL
727	NULL
can	NULL
occur	NULL
independently	NULL
of	NULL
DNA	NULL
binding	NULL
or	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Phorbol	NULL
esters	NULL
are	NULL
pharmacological	NULL
activators	NULL
of	NULL
the	NULL
ERK	NULL
pathway	NULL
and	NULL
to	NULL
examine	NULL
whether	NULL
a	NULL
more	NULL
physiological	NULL
signal	NULL
for	NULL
ERK	NULL
activation	NULL
can	NULL
induce	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
proteins	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
triggering	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
complex	NULL
on	NULL
STAT3	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
triggering	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
complex	NULL
does	NULL
not	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
(	NULL
31	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

6D	NULL
show	NULL
that	NULL
STAT3a	NULL
«	NULL
proteins	NULL
isolated	NULL
from	NULL
TCR-acti-vated	NULL
T	NULL
cells	NULL
are	NULL
reactive	NULL
with	NULL
the	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
antisera	NULL
compared	NULL
with	NULL
the	NULL
weak	NULL
reactivity	NULL
seen	NULL
in	NULL
STAT3a	NULL
@	NULL
proteins	NULL
isolated	NULL
from	NULL
quiescent	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
STAT3	NULL
«	NULL
can	NULL
be	NULL
phosphorylated	NULL
on	NULL
serine	NULL
727	NULL
in	NULL
response	NULL
to	NULL
triggering	NULL
the	NULL
TCR	NULL
complex	NULL
.	NULL

This	NULL
effect	NULL
is	NULL
prevented	NULL
by	NULL
pretreating	NULL
T	NULL
cells	NULL
with	NULL
the	NULL
MEK	NULL
inhibitor	NULL
PDO98059	NULL
;	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
in	NULL
which	NULL
TCR	NULL
regulation	NULL
of	NULL
the	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
being	NULL
mediated	NULL
by	NULL
the	NULL
MEK/ERK	NULL
pathway	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
)	NULL
.	NULL

IL-2	NULL
Induced	NULL
STAT3	NULL
but	NULL
Not	NULL
STAT5	NULL
DNA	NULL
Binding	NULL
Is	NULL
Regulated	NULL
by	NULL
a	NULL
H-7	NULL
Serine	NULL
Kinase	NULL
Pathway-The	NULL
data	NULL
above	NULL
show	NULL
that	NULL
IL-2	NULL
regulates	NULL
a	NULL
MEK-sensitive	NULL
serine	NULL
kinase	NULL
that	NULL
is	NULL
acting	NULL
on	NULL
serine	NULL
727	NULL
in	NULL
the	NULL
COOH	NULL
terminus	NULL
of	NULL
STAT3a	NULL
@	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
this	NULL
MEK-dependent	NULL
pathway	NULL
is	NULL
not	NULL
necessary	NULL
or	NULL
with	NULL
IL-2	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
,	NULL
or	NULL
PDBu	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
acetone-precipitated	NULL
proteins	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
blot	NULL
using	NULL
STATS5	NULL
and	NULL
STAT3	NULL
antibodies	NULL
.	NULL

B	NULL
,	NULL
panel	NULL
a	NULL
,	NULL
Kit225	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
above	NULL
followed	NULL
by	NULL
Western	NULL
analysis	NULL
using	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
(	NULL
Zanes	NULL
1-3	NULL
)	NULL
or	NULL
STAT3	NULL
antibodies	NULL
(	NULL
Zanes	NULL
4-6	NULL
)	NULL
.	NULL

B	NULL
,	NULL
panel	NULL
b	NULL
,	NULL
Kit225	NULL
cells	NULL
were	NULL
treated	NULL
as	NULL
above	NULL
and	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
followed	NULL
by	NULL
immunoprecipitation	NULL
using	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
antibodies	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
detected	NULL
by	NULL
Western	NULL
analysis	NULL
using	NULL
STAT3	NULL
antibodies	NULL
.	NULL

C	NULL
,	NULL
Kit225	NULL
were	NULL
treated	NULL
as	NULL
above	NULL
and	NULL
DNA-binding	NULL
proteins	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
SIEM-oligonucleotide	NULL
were	NULL
affinity	NULL
purified	NULL
and	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
blot	NULL
using	NULL
STAT5	NULL
and	NULL
STAT3	NULL
antibodies	NULL
(	NULL
as	NULL
indicated	NULL
)	NULL
.	NULL

D	NULL
,	NULL
quiescent	NULL
T	NULL
lymphoblasts	NULL
were	NULL
untreated	NULL
or	NULL
stimulated	NULL
with	NULL
IL-2	NULL
(	NULL
1	NULL
nM	NULL
)	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
or	NULL
UCHT-1	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
(	NULL
Zanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
for	NULL
10	NULL
min	NULL
following	NULL
a	NULL
30-min	NULL
preincubation	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Zanes	NULL
1-3	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
of	NULL
MEK	NULL
inhibitor	NULL
PDO98059	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
STAT	NULL
proteins	NULL
were	NULL
affinity	NULL
purified	NULL
using	NULL
agarose-conjugated	NULL
tyrosine	NULL
phosphopeptides	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
Western	NULL
blot	NULL
using	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
antibodies	NULL
.	NULL

Positions	NULL
of	NULL
molecular	NULL
weight	NULL
markers	NULL
on	NULL
the	NULL
left	NULL
are	NULL
indicated	NULL
in	NULL
kDa	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
STAT3	NULL
Regulation	NULL
in	NULL
T	NULL
Cells	NULL
IL-2	NULL
-~	NULL
+	NULL
+o	NULL
+0	NULL
+o	NULL
4+	NULL
O+	NULL
BLOT	NULL
Inhibitor	NULL
LM	NULL
PDs	NULL
PD	NULL
:	NULL
s	NULL
PD	NULL
»	NULL
PD	NULL
:	NULL
H-7z	NULL
wl	NULL
ry	NULL
®	NULL
a-STAT	NULL
30s	NULL
«	NULL
-STAT3	NULL
STAT	NULL
30	NULL
f	NULL
low	NULL
exposure	NULL
a-STAT	NULL
3	NULL
+-STAT	NULL
30	NULL
+-STAT	NULL
38	NULL
-s	NULL
;	NULL
s	NULL
+-STAT	NULL
30s	NULL
TA	NULL
``	NULL
(	NULL
oe	NULL
e	NULL
Og	NULL
was	NULL
|	NULL
30s	NULL
-	NULL
copy	NULL
STAT	NULL
'	NULL
+-STAT	NULL
36	NULL
1	NULL
r00	NULL
300	NULL
«	NULL
00	NULL
s	NULL
000	NULL
%	NULL
7	NULL
BLOT	NULL
w-P-Tyr	NULL
«	NULL
-STAT	NULL
5	NULL
a-STAT	NULL
3	NULL
C	NULL
Ligand	NULL
200	NULL
L2	NULL
0	NULL
IL2	NULL
o	NULL
IL2	NULL
Inhibitor	NULL
s	NULL
-	NULL
PD	NULL
H-7	NULL
97	NULL
«	NULL
w	NULL
W694	NULL
:	NULL
«	NULL
mn	NULL
.	NULL

68	NULL
E	NULL
1	NULL
2	NULL
3	NULL
p	NULL
BLOT	NULL
a-STAT3	NULL
pS	NULL
727	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Serine	NULL
kinase	NULL
inhibitor	NULL
H-7	NULL
but	NULL
not	NULL
PDO98059	NULL
inhibits	NULL
DNA	NULL
binding	NULL
of	NULL
STAT3a	NULL
«	NULL
and	NULL
STAT3B	NULL
.	NULL

H-7	NULL
does	NULL
not	NULL
target	NULL
IL-2	NULL
induced	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
on	NULL
STATS8a	NULL
.	NULL

A	NULL
,	NULL
Kit225	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
treated	NULL
(	NULL
Zanes	NULL
2-7	NULL
)	NULL
with	NULL
IL-2	NULL
for	NULL
10	NULL
min	NULL
following	NULL
preincubation	NULL
with	NULL
the	NULL
indicated	NULL
micromolar	NULL
concentrations	NULL
of	NULL
PDO98059	NULL
(	NULL
lanes	NULL
3-6	NULL
)	NULL
or	NULL
200	NULL
um	NULL
H-7	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
subjected	NULL
to	NULL
acetone	NULL
precipitation	NULL
,	NULL
followed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
STAT3	NULL
and	NULL
phosphotyrosine	NULL
(	NULL
Tyr	NULL
(	NULL
P	NULL
)	NULL
-705	NULL
)	NULL
STAT3	NULL
antibodies	NULL
(	NULL
both	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
.	NULL

A	NULL
low	NULL
exposure	NULL
is	NULL
also	NULL
shown	NULL
to	NULL
highlight	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
of	NULL
STAT3a	NULL
@	NULL
,	NULL
no	NULL
difference	NULL
in	NULL
mobility	NULL
shift	NULL
of	NULL
STATSRG	NULL
was	NULL
detected	NULL
.	NULL

On	NULL
total	NULL
lysates	NULL
,	NULL
the	NULL
phosphotyrosine	NULL
(	NULL
Tyr	NULL
(	NULL
P	NULL
)	NULL
705	NULL
)	NULL
STAT3	NULL
antibody	NULL
is	NULL
also	NULL
cross-reactive	NULL
with	NULL
STAT5	NULL
(	NULL
indicated	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Kit225	NULL
cells	NULL
were	NULL
untreated	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
stimulated	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
with	NULL
IL-2	NULL
,	NULL
after	NULL
a	NULL
30-min	NULL
preincubation	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
odd	NULL
lanes	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
even	NULL
lanes	NULL
)	NULL
of	NULL
H-7	NULL
(	NULL
200	NULL
um	NULL
)	NULL
.	NULL

SIEM-binding	NULL
proteins	NULL
were	NULL
affinity	NULL
purified	NULL
,	NULL
and	NULL
detected	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
4G10/PY20	NULL
(	NULL
phosphotyrosine	NULL
)	NULL
,	NULL
STATS5	NULL
and	NULL
STAT3	NULL
antibodies	NULL
.	NULL

C	NULL
,	NULL
Kit225	NULL
cells	NULL
were	NULL
untreated	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
IL-2	NULL
(	NULL
Zanes	NULL
2-4	NULL
)	NULL
for	NULL
10	NULL
min	NULL
following	NULL
80	NULL
min	NULL
preincubation	NULL
with	NULL
either	NULL
50	NULL
um	NULL
PDO98059	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
or	NULL
200	NULL
uM	NULL
H-7	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
proteins	NULL
were	NULL
acetone	NULL
precipitated	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
antibodies	NULL
.	NULL

sufficient	NULL
for	NULL
induction	NULL
of	NULL
STAT3a	NULL
@	NULL
DNA	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
and	NULL
6C	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
MEK	NULL
inhibitor	NULL
PDO98059	NULL
inhibits	NULL
STAT3a	NULL
@	NULL
serine	NULL
727	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
,	NULL
the	NULL
data	NULL
24547	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
show	NULL
that	NULL
pretreatment	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
the	NULL
MEK	NULL
inhibitor	NULL
does	NULL
not	NULL
abrogate	NULL
IL-2	NULL
induced	NULL
STAT3w/B	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lane	NULL
2	NULL
versus	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
the	NULL
MEK	NULL
pathway	NULL
can	NULL
control	NULL
STAT3a	NULL
phosphorylation	NULL
on	NULL
serine	NULL
727	NULL
,	NULL
its	NULL
activity	NULL
is	NULL
not	NULL
required	NULL
for	NULL
IL-2	NULL
induced	NULL
DNA	NULL
binding	NULL
of	NULL
STAT3	NULL
«	NULL
or	NULL
STAT3	NULL
$	NULL
or	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

In	NULL
certain	NULL
cells	NULL
,	NULL
cytokine	NULL
induction	NULL
of	NULL
STAT3	NULL
DNA	NULL
binding	NULL
can	NULL
be	NULL
regulated	NULL
by	NULL
a	NULL
serine	NULL
kinase	NULL
pathway	NULL
sensitive	NULL
to	NULL
the	NULL
serine/	NULL
threonine	NULL
kinase	NULL
inhibitor	NULL
H-7	NULL
(	NULL
24	NULL
)	NULL
.	NULL

H-7	NULL
does	NULL
not	NULL
block	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
MEK/ERK	NULL
pathway	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
28	NULL
)	NULL
but	NULL
the	NULL
role	NULL
of	NULL
H-7-sensitive	NULL
kinases	NULL
in	NULL
IL-2/STAT3	NULL
regulation	NULL
in	NULL
T	NULL
cells	NULL
had	NULL
not	NULL
been	NULL
examined	NULL
.	NULL

We	NULL
considered	NULL
the	NULL
possibility	NULL
that	NULL
STAT3	NULL
could	NULL
be	NULL
regulated	NULL
by	NULL
two	NULL
different	NULL
serine	NULL
kinases	NULL
.	NULL

We	NULL
therefore	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
H-7	NULL
pretreatment	NULL
of	NULL
T	NULL
cells	NULL
on	NULL
IL-2	NULL
regulation	NULL
of	NULL
STAT3	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

7B	NULL
shows	NULL
that	NULL
IL-2	NULL
induced	NULL
STAT3	NULL
@	NULL
/B	NULL
DNA	NULL
binding	NULL
was	NULL
inhibited	NULL
in	NULL
T	NULL
cells	NULL
pretreated	NULL
with	NULL
H-7	NULL
.	NULL

H-7	NULL
did	NULL
not	NULL
inhibit	NULL
IL-2-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
@	NULL
/B	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lane	NULL
2	NULL
versus	NULL
7	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
H-7	NULL
on	NULL
STAT3	NULL
DNA	NULL
binding	NULL
showed	NULL
selectivity	NULL
since	NULL
this	NULL
inhibitor	NULL
did	NULL
not	NULL
prevent	NULL
IL-2	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
or	NULL
STATS	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Nor	NULL
was	NULL
DNA	NULL
binding	NULL
of	NULL
STATS5	NULL
proteins	NULL
affected	NULL
by	NULL
H-7	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
although	NULL
as	NULL
described	NULL
previously	NULL
,	NULL
H-7	NULL
inhibits	NULL
the	NULL
generation	NULL
of	NULL
the	NULL
serine-phosphorylated	NULL
STAT5	NULL
p2	NULL
form	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
effect	NULL
of	NULL
H-7	NULL
on	NULL
IL-2-induced	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
of	NULL
STATS	NULL
proteins	NULL
.	NULL

(	NULL
28	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

The	NULL
inhibitor	NULL
H-7	NULL
also	NULL
did	NULL
not	NULL
prevent	NULL
the	NULL
formation	NULL
of	NULL
hyperphosphorylated	NULL
STAT3	NULL
«	NULL
@	NULL
in	NULL
IL-2-activated	NULL
cells	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
MEK	NULL
inhibitor	NULL
PDO98059	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
lane	NULL
7	NULL
versus	NULL
lane	NULL
3	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Concurrently	NULL
,	NULL
STAT3	NULL
«	NULL
proteins	NULL
from	NULL
IL-2	NULL
activated	NULL
,	NULL
H-7-pretreated	NULL
T	NULL
cells	NULL
were	NULL
also	NULL
reactive	NULL
with	NULL
phosphoserine	NULL
727	NULL
STAT3	NULL
antisera	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
,	NULL
demonstrating	NULL
that	NULL
H-7	NULL
in	NULL
T	NULL
cells	NULL
does	NULL
not	NULL
inhibit	NULL
IL-2-induced	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
in	NULL
STAT3	NULL
@	NULL
.	NULL

Thus	NULL
,	NULL
H-7	NULL
inhibits	NULL
IL-2	NULL
induction	NULL
of	NULL
STAT3	NULL
DNA	NULL
bound	NULL
complexes	NULL
without	NULL
preventing	NULL
tyrosine	NULL
phosphorylation	NULL
or	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
in	NULL
STAT3a	NULL
.	NULL

DISCUSSION	NULL
The	NULL
present	NULL
study	NULL
reveals	NULL
that	NULL
IL-2	NULL
activates	NULL
DNA	NULL
binding	NULL
of	NULL
two	NULL
forms	NULL
of	NULL
STAT3	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
90-kDa	NULL
STAT3	NULL
«	NULL
@	NULL
and	NULL
an	NULL
83-kDa	NULL
carboxyl-terminal	NULL
truncated	NULL
We	NULL
show	NULL
moreover	NULL
that	NULL
STAT3	NULL
proteins	NULL
are	NULL
both	NULL
tyrosine-	NULL
and	NULL
serine-phosphorylated	NULL
in	NULL
IL-2-activated	NULL
T	NULL
cells	NULL
.	NULL

Notably	NULL
,	NULL
we	NULL
developed	NULL
a	NULL
specific	NULL
antibody	NULL
reactive	NULL
with	NULL
phosphorylated	NULL
serine	NULL
727	NULL
in	NULL
STAT3	NULL
«	NULL
and	NULL
show	NULL
that	NULL
STAT3a	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
MEK	NULL
regulated	NULL
pathway	NULL
that	NULL
is	NULL
not	NULL
required	NULL
for	NULL
STAT3	NULL
DNA	NULL
binding	NULL
but	NULL
which	NULL
specifically	NULL
targets	NULL
the	NULL
site	NULL
serine	NULL
727	NULL
required	NULL
for	NULL
STAT3	NULL
«	NULL
maximal	NULL
transcriptional	NULL
activity	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
present	NULL
results	NULL
also	NULL
reveal	NULL
that	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
in	NULL
STAT3a	NULL
«	NULL
is	NULL
not	NULL
only	NULL
regulated	NULL
by	NULL
IL-2	NULL
but	NULL
can	NULL
be	NULL
regulated	NULL
by	NULL
the	NULL
TCR	NULL
or	NULL
phorbol	NULL
esters	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

IL-2	NULL
activation	NULL
of	NULL
STAT3	NULL
concurrently	NULL
induces	NULL
phosphorylation	NULL
on	NULL
serine	NULL
727	NULL
and	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

However	NULL
,	NULL
STAT3	NULL
phosphorylation	NULL
on	NULL
serine	NULL
727	NULL
in	NULL
response	NULL
to	NULL
TCR	NULL
ligation	NULL
or	NULL
phorbol	NULL
esters	NULL
occurs	NULL
without	NULL
concomitant	NULL
induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
or	NULL
DNA	NULL
binding	NULL
of	NULL
STAT3	NULL
.	NULL

Accordingly	NULL
,	NULL
the	NULL
serine	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
pathways	NULL
that	NULL
target	NULL
the	NULL
STATs	NULL
can	NULL
be	NULL
controlled	NULL
independently	NULL
by	NULL
extracellular	NULL
stimuli	NULL
.	NULL

A	NULL
continual	NULL
challenge	NULL
in	NULL
T	NULL
cell	NULL
biology	NULL
is	NULL
to	NULL
understand	NULL
the	NULL
mechanisms	NULL
that	NULL
regulate	NULL
the	NULL
immune	NULL
specificity	NULL
of	NULL
T	NULL
cell	NULL
responses	NULL
.	NULL

Phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
in	NULL
STAT3a	NULL
is	NULL
required	NULL
for	NULL
maximal	NULL
STAT3	NULL
transcriptional	NULL
activity	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
respond	NULL
to	NULL
TCR	NULL
triggering	NULL
by	NULL
inducing	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
on	NULL
a	NULL
residue	NULL
that	NULL
is	NULL
key	NULL
for	NULL
STAT3	NULL
transcriptional	NULL
activity	NULL
reveals	NULL
that	NULL
in	NULL
T	NULL
cells	NULL
there	NULL
is	NULL
``	NULL
crosstalk	NULL
``	NULL
regulation	NULL
of	NULL
the	NULL
STAT	NULL
's	NULL
by	NULL
members	NULL
of	NULL
the	NULL
antigen	NULL
receptor	NULL
family	NULL
.	NULL

This	NULL
allows	NULL
the	NULL
transcriptional	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
24548	NULL
IL-2R	NULL
PdBu	NULL
<	NULL
lib	NULL
\	NULL
on	NULL
'	NULL
``	NULL
H-7	NULL
sensitive	NULL
?	NULL

!	NULL

kinase	NULL
pathway	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
the	NULL
pathways	NULL
that	NULL
converge	NULL
to	NULL
regulate	NULL
STAT3	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

During	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
activates	NULL
the	NULL
MEK/ERK	NULL
pathway	NULL
.	NULL

This	NULL
phospho-rylates	NULL
STAT8a	NULL
@	NULL
on	NULL
serine	NULL
727	NULL
.	NULL

Subsequent	NULL
engagement	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
results	NULL
in	NULL
phosphorylation	NULL
of	NULL
tyrosine	NULL
705	NULL
of	NULL
STAT3	NULL
@	NULL
«	NULL
and	NULL
its	NULL
SH2-mediated	NULL
dimerization	NULL
and	NULL
induction	NULL
of	NULL
DNA	NULL
binding	NULL
.	NULL

IL-2	NULL
can	NULL
also	NULL
induce	NULL
the	NULL
MEK/ERK-mediated	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
.	NULL

A	NULL
second	NULL
,	NULL
unidentified	NULL
,	NULL
H-7-sensitive	NULL
pathway	NULL
can	NULL
also	NULL
regulate	NULL
STAT3	NULL
DNA	NULL
binding	NULL
in	NULL
IL-2-activated	NULL
T	NULL
cells	NULL
.	NULL

activity	NULL
of	NULL
STAT3a	NULL
@	NULL
in	NULL
T	NULL
cells	NULL
to	NULL
be	NULL
linked	NULL
to	NULL
the	NULL
immune	NULL
activation	NULL
status	NULL
of	NULL
the	NULL
cells	NULL
;	NULL
a	NULL
link	NULL
which	NULL
may	NULL
facilitate	NULL
the	NULL
immune	NULL
specificity	NULL
of	NULL
T	NULL
cell	NULL
responses	NULL
.	NULL

The	NULL
inhibitor	NULL
H-7	NULL
has	NULL
been	NULL
one	NULL
tool	NULL
with	NULL
which	NULL
to	NULL
explore	NULL
STAT	NULL
serine	NULL
kinases	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
systems	NULL
,	NULL
particularly	NULL
,	NULL
the	NULL
regulation	NULL
of	NULL
STAT3	NULL
by	NULL
H-7-sensitive	NULL
kinases	NULL
has	NULL
been	NULL
described	NULL
.	NULL

Because	NULL
of	NULL
these	NULL
previous	NULL
experiments	NULL
with	NULL
H-7	NULL
we	NULL
were	NULL
prompted	NULL
to	NULL
see	NULL
whether	NULL
H-7	NULL
could	NULL
regulate	NULL
the	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
in	NULL
STAT3	NULL
@	NULL
.	NULL

The	NULL
present	NULL
study	NULL
shows	NULL
that	NULL
IL-2-induced	NULL
STAT3	NULL
DNA	NULL
binding	NULL
can	NULL
be	NULL
regulated	NULL
by	NULL
a	NULL
H-7-sensitive	NULL
pathway	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
H-7-sensitive	NULL
pathway	NULL
does	NULL
not	NULL
regulate	NULL
STAT3	NULL
«	NULL
@	NULL
serine	NULL
727	NULL
phosphorylation	NULL
.	NULL

The	NULL
H-7	NULL
target	NULL
is	NULL
unknown	NULL
but	NULL
is	NULL
intriguing	NULL
because	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
H-7	NULL
on	NULL
STAT3	NULL
DNA	NULL
binding	NULL
.	NULL

The	NULL
simplest	NULL
interpretation	NULL
of	NULL
the	NULL
H-7	NULL
data	NULL
is	NULL
that	NULL
STAT3a	NULL
«	NULL
integrates	NULL
signals	NULL
from	NULL
two	NULL
serine	NULL
kinase	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
a	NULL
MEK-regulated	NULL
pathway	NULL
and	NULL
a	NULL
H-7-sensitive	NULL
pathway	NULL
.	NULL

These	NULL
pathways	NULL
are	NULL
independent	NULL
as	NULL
H-7	NULL
does	NULL
not	NULL
prevent	NULL
IL-2	NULL
activation	NULL
of	NULL
the	NULL
MEK/ERK2	NULL
pathway	NULL
(	NULL
28	NULL
)	NULL
or	NULL
the	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
in	NULL
STAT3	NULL
«	NULL
.	NULL

H-7	NULL
,	NULL
however	NULL
,	NULL
does	NULL
inhibit	NULL
IL-2-activated	NULL
STAT3	NULL
DNA	NULL
binding	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Conversely	NULL
,	NULL
the	NULL
MEK/ERK2	NULL
pathway	NULL
regulates	NULL
phosphorylation	NULL
of	NULL
serine	NULL
727	NULL
in	NULL
STAT3a	NULL
«	NULL
but	NULL
is	NULL
not	NULL
necessary	NULL
for	NULL
IL-2	NULL
induced	NULL
STAT3	NULL
DNA	NULL
binding	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
both	NULL
STAT3	NULL
«	NULL
and	NULL
DNA	NULL
binding	NULL
indicates	NULL
that	NULL
the	NULL
H-7-sensitive	NULL
pathway	NULL
must	NULL
regulate	NULL
a	NULL
site	NULL
outside	NULL
the	NULL
variant	NULL
carboxyl	NULL
termini	NULL
of	NULL
the	NULL
two	NULL
forms	NULL
of	NULL
STAT3	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
through	NULL
a	NULL
H-7-sensitive	NULL
kinase	NULL
,	NULL
phosphorylation	NULL
at	NULL
,	NULL
or	NULL
close	NULL
to	NULL
,	NULL
the	NULL
DNA-binding	NULL
domain	NULL
increases	NULL
DNA	NULL
binding	NULL
affinity	NULL
of	NULL
STAT3	NULL
proteins	NULL
.	NULL

Nevertheless	NULL
,	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
the	NULL
H-7	NULL
effect	NULL
on	NULL
STAT3	NULL
proteins	NULL
is	NULL
indirect	NULL
and	NULL
mediated	NULL
through	NULL
association	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
or	NULL
co-factors	NULL
;	NULL
H-7-inhibited	NULL
phosphorylation	NULL
of	NULL
these	NULL
associated	NULL
factors	NULL
could	NULL
contribute	NULL
to	NULL
a	NULL
loss	NULL
in	NULL
STAT3	NULL
DNA	NULL
binding	NULL
affinity	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
previously	NULL
that	NULL
IL-2	NULL
activation	NULL
of	NULL
STATS5	NULL
involves	NULL
the	NULL
convergent	NULL
action	NULL
of	NULL
both	NULL
tyrosine	NULL
and	NULL
serine/	NULL
threonine	NULL
kinases	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
STATS	NULL
serine	NULL
kinase	NULL
is	NULL
H-7	NULL
sensitive	NULL
and	NULL
not	NULL
regulated	NULL
by	NULL
MEK	NULL
and	NULL
can	NULL
not	NULL
be	NULL
stimulated	NULL
by	NULL
activators	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
cascade	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Herein	NULL
we	NULL
show	NULL
that	NULL
the	NULL
STAT3	NULL
727	NULL
serine	NULL
kinase	NULL
is	NULL
sensitive	NULL
to	NULL
a	NULL
MEK	NULL
inhibitor	NULL
and	NULL
can	NULL
be	NULL
stimulated	NULL
by	NULL
receptors	NULL
that	NULL
activate	NULL
the	NULL
MEK	NULL
cascade	NULL
independently	NULL
of	NULL
STAT	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

The	NULL
STAT3	NULL
Regulation	NULL
in	NULL
T	NULL
Cells	NULL
involvement	NULL
of	NULL
the	NULL
MEK	NULL
pathway	NULL
clearly	NULL
distinguishes	NULL
IL-2	NULL
regulation	NULL
of	NULL
STAT3a	NULL
and	NULL
STAT5	NULL
and	NULL
shows	NULL
how	NULL
a	NULL
single	NULL
cytokine	NULL
working	NULL
in	NULL
the	NULL
same	NULL
cell	NULL
can	NULL
use	NULL
distinct	NULL
serine	NULL
kinase	NULL
pathways	NULL
to	NULL
regulate	NULL
different	NULL
STAT	NULL
's	NULL
.	NULL

There	NULL
has	NULL
been	NULL
considerable	NULL
debate	NULL
as	NULL
to	NULL
the	NULL
identity	NULL
of	NULL
STAT	NULL
serine	NULL
kinases	NULL
.	NULL

The	NULL
present	NULL
results	NULL
show	NULL
that	NULL
regarding	NULL
the	NULL
identity	NULL
of	NULL
STAT	NULL
serine	NULL
kinases	NULL
may	NULL
reflect	NULL
that	NULL
cytokines	NULL
can	NULL
target	NULL
STAT	NULL
's	NULL
involving	NULL
multiple	NULL
and	NULL
functionally	NULL
different	NULL
serine	NULL
kinase	NULL
pathways	NULL
.	NULL

The	NULL
MEK/ERK	NULL
pathway	NULL
is	NULL
known	NULL
to	NULL
have	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
responses	NULL
of	NULL
mature	NULL
T	NULL
cells	NULL
and	NULL
in	NULL
thymocyte	NULL
differentiation	NULL
:	NULL
the	NULL
transition	NULL
of	NULL
thymocytes	NULL
from	NULL
double	NULL
negative	NULL
to	NULL
double	NULL
positive	NULL
cells	NULL
requires	NULL
MEK/ERK2	NULL
activity	NULL
as	NULL
does	NULL
positive	NULL
selection	NULL
of	NULL
thymocytes	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
importance	NULL
of	NULL
this	NULL
pathway	NULL
,	NULL
few	NULL
MEK	NULL
regulated	NULL
pathways	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

We	NULL
now	NULL
show	NULL
that	NULL
serine	NULL
727	NULL
,	NULL
a	NULL
residue	NULL
critical	NULL
for	NULL
STAT3	NULL
function	NULL
,	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
the	NULL
action	NULL
of	NULL
the	NULL
MEK	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
serine	NULL
727	NULL
in	NULL
STAT3a	NULL
can	NULL
be	NULL
phosphorylated	NULL
by	NULL
the	NULL
MEK/ERK	NULL
pathway	NULL
not	NULL
only	NULL
in	NULL
response	NULL
to	NULL
the	NULL
cytokine	NULL
IL-2	NULL
but	NULL
also	NULL
in	NULL
response	NULL
to	NULL
triggering	NULL
of	NULL
the	NULL
antigen	NULL
receptor	NULL
complex	NULL
.	NULL

The	NULL
present	NULL
results	NULL
demonstrate	NULL
serine	NULL
phosphorylation	NULL
of	NULL
residue	NULL
727	NULL
can	NULL
occur	NULL
independently	NULL
of	NULL
STAT3	NULL
«	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
STAT3	NULL
DNA	NULL
binding	NULL
and	NULL
maximal	NULL
transcriptional	NULL
activity	NULL
are	NULL
separate	NULL
processes	NULL
.	NULL

These	NULL
data	NULL
collectively	NULL
reveal	NULL
the	NULL
complexity	NULL
of	NULL
STAT	NULL
regulation	NULL
and	NULL
show	NULL
that	NULL
STATs	NULL
are	NULL
not	NULL
only	NULL
targets	NULL
for	NULL
members	NULL
of	NULL
the	NULL
cytokine	NULL
receptor	NULL
family	NULL
in	NULL
T	NULL
cells	NULL
but	NULL
can	NULL
also	NULL
integrate	NULL
diverse	NULL
MAP	NULL
kinase	NULL
signals	NULL
notably	NULL
,	NULL
signals	NULL
from	NULL
antigen	NULL
receptors	NULL
.	NULL

Acknowledgments-We	NULL
acknowledge	NULL
and	NULL
thank	NULL
N.	NULL
O'Reilly	NULL
and	NULL
E.	NULL
Li	NULL
for	NULL
peptide	NULL
synthesis	NULL
,	NULL
and	NULL
K.	NULL
Hobbs	NULL
for	NULL
oligonucleotide	NULL
synthesis	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Ian	NULL
Kerr	NULL
,	NULL
Julian	NULL
Downward	NULL
,	NULL
and	NULL
members	NULL
of	NULL
the	NULL
Lymphocyte	NULL
Activation	NULL
Laboratory	NULL
for	NULL
valuable	NULL
discussions	NULL
.	NULL

REFERENCES	NULL
.	NULL

Smith	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Science	NULL
240	NULL
,	NULL
1169-1176	NULL
2	NULL
.	NULL

Johnston	NULL
,	NULL
J.	NULL
,	NULL
Kawamura	NULL
,	NULL
M.	NULL
,	NULL
Kirken	NULL
,	NULL
R.	NULL
,	NULL
Chen	NULL
,	NULL
Y.	NULL
,	NULL
Blake	NULL
,	NULL
T.	NULL
,	NULL
Shibuya	NULL
,	NULL
K.	NULL
,	NULL
Ortaldo	NULL
,	NULL
J.	NULL
,	NULL
McVicar	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
O'Shea	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Nature	NULL
870	NULL
,	NULL
151-158	NULL
3	NULL
.	NULL

Witthubn	NULL
,	NULL
B.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Mura	NULL
,	NULL
O.	NULL
,	NULL
Lai	NULL
,	NULL
K.	NULL
,	NULL
Cwik	NULL
,	NULL
C.	NULL
,	NULL
Liu	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Thle	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Nature	NULL
870	NULL
,	NULL
158-157	NULL
4	NULL
.	NULL

Hatakeyama	NULL
,	NULL
M.	NULL
,	NULL
Kono	NULL
,	NULL
T.	NULL
,	NULL
Kobayashi	NULL
,	NULL
N.	NULL
,	NULL
Kawahara	NULL
,	NULL
A.	NULL
,	NULL
Levin	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Perlmutter	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
252	NULL
,	NULL
1528-1528	NULL
5	NULL
.	NULL

Izquierdo	NULL
Pastor	NULL
,	NULL
M.	NULL
,	NULL
Reif	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
16	NULL
,	NULL
159-164	NULL
6	NULL
.	NULL

Turner	NULL
,	NULL
B.	NULL
,	NULL
Rapp	NULL
,	NULL
U.	NULL
,	NULL
App	NULL
,	NULL
H.	NULL
,	NULL
Greene	NULL
,	NULL
M.	NULL
,	NULL
Dobashi	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Reed	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
1227-1232	NULL
7	NULL
.	NULL

Monfar	NULL
,	NULL
M.	NULL
,	NULL
Lemon	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
Grammer	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Cheatham	NULL
,	NULL
L.	NULL
,	NULL
Chung	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Viahos	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
and	NULL
Blenis	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
326-837	NULL
8	NULL
.	NULL

Karnitz	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Burns	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Sutor	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Blenis	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Abraham	NULL
,	NULL
R.	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
3049-8057	NULL
9	NULL
.	NULL

Augustine	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Sutor	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
Abraham	NULL
,	NULL
R.	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
4431-4440	NULL
10	NULL
.	NULL

Merida	NULL
,	NULL
L.	NULL
,	NULL
Diez	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Gaulton	NULL
,	NULL
G.	NULL
N.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

147	NULL
,	NULL
2202-2207	NULL
11	NULL
.	NULL

Remillard	NULL
,	NULL
B.	NULL
,	NULL
Petrillo	NULL
,	NULL
R.	NULL
,	NULL
Maslinski	NULL
,	NULL
W.	NULL
,	NULL
Tsudo	NULL
,	NULL
M.	NULL
,	NULL
Strom	NULL
,	NULL
T.	NULL
B.	NULL
,	NULL
Cantley	NULL
,	NULL
L..	NULL
,	NULL
and	NULL
Varticovaki	NULL
,	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
14167-14170	NULL
12	NULL
.	NULL

Calvo	NULL
,	NULL
V.	NULL
,	NULL
Crews	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Vik	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Bierer	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
7571-7575	NULL
13	NULL
.	NULL

Kuo	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Jongkyeong	NULL
,	NULL
C.	NULL
,	NULL
Fiorentino	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Flanagan	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Blenis	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
858	NULL
,	NULL
70-73	NULL
14	NULL
.	NULL

Sawami	NULL
,	NULL
H.	NULL
,	NULL
Terada	NULL
,	NULL
N.	NULL
,	NULL
Franklin	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Okawa	NULL
,	NULL
H.	NULL
,	NULL
Uchiyama	NULL
,	NULL
T.	NULL
,	NULL
Lucas	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Gelfand	NULL
,	NULL
E.	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

151	NULL
,	NULL
867-877	NULL
15	NULL
.	NULL

Lin	NULL
,	NULL
J.-X	NULL
.	NULL

,	NULL
Migone	NULL
,	NULL
T.-S.	NULL
,	NULL
Tsang	NULL
,	NULL
M.	NULL
,	NULL
Friedmann	NULL
,	NULL
M.	NULL
,	NULL
Weatherbee	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Zhou	NULL
,	NULL
L.	NULL
,	NULL
Yamauchi	NULL
,	NULL
A.	NULL
,	NULL
Bloom	NULL
,	NULL
E.	NULL
T.	NULL
,	NULL
Mietz	NULL
,	NULL
J.	NULL
,	NULL
John	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Immunity	NULL
2	NULL
,	NULL
881-889	NULL
16	NULL
.	NULL

Wakao	NULL
,	NULL
H.	NULL
,	NULL
Harada	NULL
,	NULL
N.	NULL
,	NULL
Kitamura	NULL
,	NULL
T.	NULL
,	NULL
Mui	NULL
,	NULL
A.	NULL
L.-F.	NULL
,	NULL
and	NULL
Miyajima	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
2527-2535	NULL
17	NULL
.	NULL

Hou	NULL
,	NULL
J.	NULL
,	NULL
Schindler	NULL
,	NULL
U.	NULL
,	NULL
Henzel	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Ho	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Brasseur	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
265	NULL
,	NULL
1701-1706	NULL
18	NULL
.	NULL

Brunn	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
Falls	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
Nilson	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
and	NULL
Abraham	NULL
,	NULL
R.	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
11628-11685	NULL
19	NULL
.	NULL

Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Shimoda	NULL
,	NULL
K.	NULL
,	NULL
Thierfelder	NULL
,	NULL
W.	NULL
,	NULL
Fischer	NULL
,	NULL
C.	NULL
,	NULL
Kim	NULL
,	NULL
A.	NULL
,	NULL
Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Cleveland	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Pierce	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Nelms	NULL
,	NULL
K.	NULL
,	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
and	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cel	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
3336-8348	NULL
20	NULL
.	NULL

Darnell	NULL
,	NULL
J.	NULL
E.	NULL
J.	NULL
,	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
and	NULL
Stark	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
264	NULL
,	NULL
1415-1421	NULL
21	NULL
.	NULL

Schmitt	NULL
Ney	NULL
,	NULL
M.	NULL
,	NULL
Happ	NULL
,	NULL
B.	NULL
,	NULL
Ball	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
and	NULL
Groner	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
3130-3134	NULL
22	NULL
.	NULL

Lutticken	NULL
,	NULL
C.	NULL
,	NULL
Coffer	NULL
,	NULL
P.	NULL
,	NULL
Yuan	NULL
,	NULL
J.	NULL
,	NULL
Schwartz	NULL
,	NULL
C.	NULL
,	NULL
Caldenhoven	NULL
,	NULL
E.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Kruijer	NULL
,	NULL
W.	NULL
,	NULL
Heinrich	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
and	NULL
Horn	NULL
,	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
FEBS	NULL
Left	NULL
.	NULL

360	NULL
,	NULL
187-1483	NULL
23	NULL
.	NULL

Boulton	NULL
,	NULL
T.	NULL
G.	NULL
,	NULL
Zhong	NULL
,	NULL
Z.	NULL
,	NULL
Wen	NULL
,	NULL
Z.	NULL
,	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
J.	NULL
,	NULL
Stahl	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Yancopoulos	NULL
,	NULL
G.	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
6915-6919	NULL
a	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29.	NULL
.	NULL

Hori	NULL
,	NULL
T.	NULL
,	NULL
Uchiyama	NULL
,	NULL
T.	NULL
,	NULL
Tsudo	NULL
,	NULL
M.	NULL
,	NULL
Umadome	NULL
,	NULL
H.	NULL
,	NULL
Ohno	NULL
,	NULL
H.	NULL
,	NULL
Fukuhara	NULL
,	NULL
S.	NULL
,	NULL
31	NULL
.	NULL

82	NULL
.	NULL

38	NULL
.	NULL

84	NULL
.	NULL

STAT3	NULL
Regulation	NULL
in	NULL
T	NULL
Cells	NULL
Zhang	NULL
,	NULL
X.	NULL
,	NULL
Blenis	NULL
,	NULL
J.	NULL
,	NULL
Li	NULL
,	NULL
H.-C.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Chen-Kiang	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
1990-1994	NULL
Wen	NULL
,	NULL
Z.	NULL
,	NULL
Zhong	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
82	NULL
,	NULL
241-250	NULL
Cho	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
Bacon	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Sudarshan	NULL
,	NULL
C.	NULL
,	NULL
Rees	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Finbloom	NULL
,	NULL
D.	NULL
,	NULL
Pine	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
.	NULL

O'Shea	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

157	NULL
,	NULL
4781-4789	NULL
Bromberg	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Horvath	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Zilong	NULL
,	NULL
W.	NULL
,	NULL
Schreiber	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1996	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

98	NULL
,	NULL
7678-7678	NULL
Beadling	NULL
,	NULL
C.	NULL
,	NULL
Ng	NULL
,	NULL
J.	NULL
,	NULL
Babbage	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
1902-1913	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1996	NULL
)	NULL
BioEssays	NULL
18	NULL
,	NULL
95-98	NULL
Kita	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Uchino	NULL
,	NULL
H.	NULL
(	NULL
1987	NULL
)	NULL
Blood	NULL
70	NULL
,	NULL
1069-1072	NULL
Beadling	NULL
,	NULL
C.	NULL
,	NULL
Guschin	NULL
,	NULL
D.	NULL
,	NULL
Witthubn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Ziemiecki	NULL
,	NULL
A.	NULL
,	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
5605-5615	NULL
Schaefer	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
Sanders	NULL
,	NULL
L.	NULL
K.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
9097-9101	NULL
Caldenhoven	NULL
,	NULL
E.	NULL
,	NULL
van	NULL
Dijk	NULL
,	NULL
T.	NULL
,	NULL
Solari	NULL
,	NULL
R.	NULL
,	NULL
Armstrong	NULL
,	NULL
J.	NULL
,	NULL
Raaijmakers	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
M.	NULL
,	NULL
Lammers	NULL
,	NULL
J.-W.	NULL
J.	NULL
,	NULL
Koenderman	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
de	NULL
Groot	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
18221-18227	NULL
Czernik	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Girault	NULL
,	NULL
J-A	NULL
,	NULL
Nairn	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Chen	NULL
,	NULL
J.	NULL
,	NULL
Synder	NULL
,	NULL
G.	NULL
,	NULL
Kebabian	NULL
,	NULL
J.	NULL
,	NULL
35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

24549	NULL
and	NULL
Greengard	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

201	NULL
,	NULL
264-283	NULL
Drago	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
and	NULL
Colyer	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
25078-25077	NULL
Coghlan	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Pillay	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
Tavare	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Siddle	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

303	NULL
,	NULL
893-839	NULL
Patton	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
Molloy	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
and	NULL
Kennedy	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
4	NULL
,	NULL
159-172	NULL
Ginty	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Kornhauser	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Thompson	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Bading	NULL
,	NULL
H.	NULL
,	NULL
Mayo	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
Takahashi	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
Greenberg	NULL
,	NULL
M.	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
260	NULL
,	NULL
2838-241	NULL
Dudley	NULL
,	NULL
D.	NULL
,	NULL
Pang	NULL
,	NULL
L.	NULL
,	NULL
Decker	NULL
,	NULL
S.	NULL
,	NULL
Bridges	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Saltiel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
7686-7689	NULL
Alessi	NULL
,	NULL
D.	NULL
,	NULL
Cuenda	NULL
,	NULL
A.	NULL
,	NULL
Cohen	NULL
,	NULL
P.	NULL
,	NULL
Dudley	NULL
,	NULL
D.	NULL
T.	NULL
,	NULL
and	NULL
Saltiel	NULL
,	NULL
A.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
27489-27494	NULL
Cherniack	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Klarlund	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Conway	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
and	NULL
Czech	NULL
,	NULL
M.	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
1485-1488	NULL
Rozakis-Adcock	NULL
,	NULL
M.	NULL
,	NULL
van	NULL
der	NULL
Geer	NULL
,	NULL
P.	NULL
,	NULL
Mbamalu	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Pawson	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Oncogene	NULL
11	NULL
,	NULL
1417-1426	NULL
Alberola-lla	NULL
,	NULL
J.	NULL
,	NULL
Hogquist	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Swan	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Bevan	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Perlmutter	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184	NULL
,	NULL
9-18	NULL
Crompton	NULL
,	NULL
T.	NULL
,	NULL
Gilmour	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
and	NULL
Owen	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Cell	NULL
86	NULL
,	NULL
248-251	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
STAT3	NULL
Is	NULL
a	NULL
Serine	NULL
Kinase	NULL
Target	NULL
in	NULL
T	NULL
Lymphocytes	NULL
:	NULL
INTERLEUKIN	NULL
2	NULL
AND	NULL
T	NULL
CELL	NULL
ANTIGEN	NULL
RECEPTOR	NULL
SIGNALS	NULL
CONVERGE	NULL
UPON	NULL
SERINE	NULL
727	NULL
Julian	NULL
Ng	NULL
and	NULL
Doreen	NULL
Cantrell	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1997	NULL
,	NULL
272:24542-24549.	NULL
doi	NULL
:	NULL
10.1074/jb0.272.39.24542	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/272/39/24542	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
44	NULL
references	NULL
,	NULL
29	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

